O-I Glass Inc DE
For the period ended Dec 31, 2024. Filed Feb 12, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 12, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Consolidated Financial Statements
1. Significant Accounting Policies
Basis of Consolidated Statements The Consolidated Financial Statements of the Company (as defined below) include the accounts of its subsidiaries. Newly acquired subsidiaries have been included in the Consolidated Financial Statements from dates of acquisition.
The Company uses the equity method of accounting for investments in which it has a significant influence and generally an ownership interest of 20% to 50%. The Company monitors other than temporary declines in fair value and records reductions in carrying values when appropriate.
Nature of Operations The Company is a leading manufacturer of glass container products. The Company’s principal product lines are glass containers for the food and beverage industries. The Company has glass container operations located in 19 countries. The principal markets and operations for the Company’s products are in the Americas and Europe.
The term “Company,” as used herein and unless otherwise stated or indicated by context, refers to Owens-Illinois, Inc. (“O-I”) prior to the Corporate Modernization (as defined below) and to O-I Glass, Inc. (“O-I Glass”) after the Corporate Modernization.
On December 26 and 27, 2019, the Company implemented the Corporate Modernization pursuant to the Agreement and Plan of Merger (the “Merger Agreement”), dated as of December 26, 2019, among O-I, O-I Glass and Paddock Enterprises, LLC (“Paddock”).
The Corporate Modernization was conducted pursuant to Section 251(g) of the General Corporation Law of the State of Delaware, which permits the creation of a holding company through a merger with a direct or indirect wholly owned subsidiary of the constituent corporation without stockholder approval. The Corporate Modernization involved a series of transactions (together with certain related transactions, the “Corporate Modernization”) pursuant to which (1) O-I formed a new holding company, O-I Glass, as a direct wholly owned subsidiary of O-I and a sister company to Owens-Illinois Group, Inc. (“O-I Group”), (2) O-I Glass formed a new Delaware limited liability company, Paddock, as a direct wholly owned subsidiary of O-I Glass, (3) O-I merged with and into Paddock, with Paddock continuing as the surviving entity and as a direct wholly owned subsidiary of O-I Glass (the “Merger”) and (4) Paddock distributed 100% of the capital stock of O-I Group to O-I Glass, as a result of which O-I Group is a direct, wholly owned subsidiary of O-I Glass and sister company to Paddock.
Upon the effectiveness of the Merger, each share of O-I stock held immediately prior to the Merger automatically converted into a right to receive an equivalent corresponding share of O-I Glass stock, having the same designations, rights, powers and preferences, qualifications, limitations, and restrictions as the corresponding share of O-I stock being converted. Immediately after the Corporate Modernization, O-I Glass had, on a consolidated basis, the same assets, businesses and operations as O-I had immediately prior to the Corporate Modernization. After the Corporate Modernization, O-I’s stockholders became stockholders of O-I Glass. The implementation of the Corporate Modernization was accounted for as a merger under common control.
Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management of the Company to make estimates and assumptions that affect certain amounts reported in the financial statements and accompanying notes. Actual results may differ from those estimates, at which time the Company would revise its estimates accordingly.
Foreign Currency Translation The assets and liabilities of non-U.S. subsidiaries are translated into U.S. dollars at year-end exchange rates and their results of operations are converted on an ongoing basis at the monthly average rate. Any related translation adjustments are recorded in accumulated other comprehensive income (loss) in share owners’ equity.
Revenue Recognition Revenue is recognized at the point in time when obligations under the terms of the Company’s contracts and related purchase orders with its customers are satisfied, which primarily takes place when products are shipped from the Company’s manufacturing or warehousing facilities to the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods, which includes estimated provisions for rebates, discounts, returns and allowances. Sales, value-added, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue.
Shipping and Handling CostsAmounts billed to customers related to shipping and handling or other pass-through items are included in net sales in the Consolidated Results of Operations.** **Shipping and handling costs are included with cost of goods sold in the Consolidated Results of Operations.
Stock-Based Compensation The Company has various stock-based compensation plans consisting of performance and restricted share awards. Costs resulting from all share-based compensation plans are required to be recognized in the financial statements. A public entity is required to measure the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award. That cost is recognized over the required service period (usually the vesting period). No compensation cost is recognized for equity instruments for which employees do not render the required service.
Cash The Company defines “cash” as cash and time deposits with maturities of three months or less when purchased. Outstanding checks in excess of funds on deposit are included in accounts payable.
Accounts ReceivableReceivables are stated at amounts estimated by management to be the net realizable value. The Company writes-off accounts receivable when it becomes apparent based upon age or customer circumstances that amounts will not be collected.
Allowance for Doubtful AccountsThe allowance for doubtful accounts is established through charges to the provision for bad debts. The Company evaluates the adequacy of the allowance for doubtful accounts on a periodic basis. The evaluation includes historical trends in collections and write-offs, information on current economic conditions and future forecasts and management’s evaluation of business risk.
Inventory Valuation Inventories are valued at the lower of cost, primarily determined on a first-in first-out basis, or net realizable value.
Goodwill Goodwill represents the excess of cost over fair value of net assets of businesses acquired. Goodwill is evaluated annually, as of October 1, for impairment or more frequently if an impairment indicator exists, by comparing the estimated fair value of each reporting unit to its carrying value. If the carrying value exceeds the fair value, an impairment charge is recorded in the period of the evaluation based on that difference.
Intangible Assets and Other Long-Lived Assets Intangible assets are amortized over the expected useful life of the asset. Amortization expense directly attributed to the manufacturing of the Company’s products is included in cost of goods sold. Amortization expense related to non-manufacturing activities is included in Selling and administrative expense and Other expense, net. The Company evaluates the recoverability of intangible assets and other long-lived assets based on undiscounted projected cash flows, excluding interest and taxes, when factors indicate that impairment may exist. If impairment exists, the asset is written down to fair value.
Property, Plant and EquipmentProperty, plant and equipment (“PP&E”) is carried at cost and includes expenditures for new facilities and equipment and those costs which substantially increase the useful lives or capacity of existing PP&E. In general, depreciation is computed using the straight-line method and recorded over the estimated useful life of the asset. Factory machinery and equipment is depreciated over periods ranging from 5 to 25 years with the majority of such assets (principally glass-melting furnaces and forming machines) depreciated over 7 to 15 years. Buildings and building equipment are depreciated over periods ranging from 10
to 50 years. Depreciation expense directly attributed to the manufacturing of the Company’s products is included in cost of goods sold. Depreciation expense related to non-manufacturing activities is included in Selling and administrative. Depreciation expense includes the amortization of assets recorded under financing leases. Maintenance and repairs are expensed as incurred. Costs assigned to PP&E of acquired businesses are based on estimated fair values at the date of acquisition. The Company evaluates the recoverability of PP&E based on undiscounted projected cash flows, excluding interest and taxes, when factors indicate that impairment may exist. If impairment exists, the asset is written down to fair value.
Derivative Instruments The Company uses derivative instruments to manage risks generally associated with foreign exchange rate, interest rate and commodity market volatility. Derivative financial instruments are included on the balance sheet at fair value. Changes in the fair value of derivative assets or liabilities (i.e., gains or losses) are recognized depending upon the type of hedging relationship and whether a hedge has been designated. For those derivative instruments that qualify for hedge accounting, the Company designates the hedging instrument, based upon the exposure being hedged, as a cash flow hedge, fair value hedge, or a hedge of a net investment in a foreign operation. For a derivative instrument designated as a fair value hedge, the gain or loss on the derivative is recognized in earnings immediately with the offsetting gain or loss on the hedged item. For a derivative instrument designated as a cash flow hedge, the effective portion of the derivative's gain or loss is initially reported as a component of Accumulated other comprehensive loss and is subsequently recognized in earnings when the hedged exposure affects earnings. If there is an ineffective portion of the change in fair value of the derivative, it is recognized directly in earnings. For a derivative instrument designated as a hedge of a net investment in a foreign operation, the effective portion of the derivative's gain or loss is reported in Accumulated other comprehensive loss as part of the cumulative translation adjustment, and amounts are reclassified out of accumulated other comprehensive loss into earnings when the hedged net investment is either sold or substantially liquidated. Changes in fair value of derivative instruments that do not qualify for hedge accounting are recognized immediately in current net earnings. The Company does not enter into derivative financial instruments for trading purposes and is not a party to leveraged derivatives. In the consolidated statement of cash flows, the settlement of derivative instruments designated as hedges is typically recorded in the category that is consistent with the nature of the underlying item being hedged. See Note 9 to the Consolidated Financial Statements for additional information about hedges and derivative financial instruments.
Fair Value Measurements Fair value is defined as the amount that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants. Generally accepted accounting principles define a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:
*Level 1:*Observable inputs such as quoted prices in active markets;
Level 2: Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and
Level 3: Unobservable inputs for which there is little or no market data, which requires the Company to develop assumptions.
The carrying amounts reported for cash and short-term loans approximate fair value. In addition, carrying amounts approximate fair value for certain long-term debt obligations subject to frequently redetermined interest rates. Fair values for the Company’s significant fixed rate debt obligations are generally based on published market quotations.
New Accounting Standards
In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” This ASU requires a public entity to provide additional information in the rate reconciliation and additional disclosures about income taxes paid. This ASU is effective for the Company for annual periods beginning after December 15, 2024. The Company is evaluating the impact of this ASU.
In November 2024, the FASB issued ASU 2024-03, “Income Statement — Reporting Comprehensive Income — Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses.” This ASU requires a public business entity to provide disaggregated disclosures, in the notes to the financial statements, of certain categories of expenses that are included in expense line items on the face of the income statement. The disclosures are required on an annual and interim basis. This ASU is effective for the Company for annual periods beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. The Company is evaluating the impact of this ASU.
2. Segment Information
The Company hastwo reportable segments andtwo operating segments based on its geographic locations: Americas and Europe. Thesetwo segments are aligned with the Company’s internal approach to managing, reporting, and evaluating performance of its global glass operations. Certain assets and activities not directly related to one of the segments or to glass manufacturing are reported with Retained corporate costs and other. These include licensing, equipment manufacturing, global engineering, certain equity investments and certain minor businesses in the Asia Pacific region. Retained corporate costs and other also includes certain headquarters administrative and facilities costs and certain incentive compensation and other benefit plan costs that are global in nature and are not allocable to the reportable segments.
The Company’s measure of profit for its reportable segments is segment operating profit, which is a non-GAAP financial measure that consists of consolidated earnings before interest income, interest expense, and provision for income taxes and excludes amounts related to certain items that management considers not representative of ongoing operations and other adjustments, as well as certain retained corporate costs. The Company’s management, including the chief operating decision maker (defined as the Chief Executive Officer), uses segment operating profit, supplemented by net sales and selected cash flow information, to evaluate segment performance and allocate resources. Segment operating profit for reportable segments includes an allocation of some corporate expenses based on both a percentage of sales and direct billings based on the costs of specific services provided. Segment operating profit is not a recognized term under accounting principles generally accepted in the United States (“U.S. GAAP”) and, therefore, does not purport to be an alternative to earnings (loss) before income taxes. Further, the Company’s measure of segment operating profit may not be comparable to similarly titled measures used by other companies.
In accordance with ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures,” the Company has disclosed significant segment expenses reviewed by its chief operating decision maker. Other segment expenses (income) includes intangible amortization expense (Americas only), foreign currency exchange gains or losses, certain overhead expenses and other gains or losses. Certain prior year presentations have been recast below to conform to these new reporting requirements.
Financial information regarding the Company’s reportable segments is as follows:
| | | | | | | | | | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| | 2024 | 2023 | 2022 | ||||||||||||||||||
| | | | Americas | | Europe | | Total | | | Americas | | Europe | | Total | | | Americas | | Europe | | Total |
| Reportable segment net sales | | $3,584 | $2,820 | $6,404 | | $3,865 | $3,117 | $6,982 | | $3,835 | $2,878 | $6,713 | |||||||||
| Other | | | | | | | 127 | | | | | | | 123 | | | | | | | 143 |
| Net Sales | | | | 6,531 | | | | | | $7,105 | | | | | | 6,856 | |||||
| | | | | | | | | | | | | | | | | | | | | | |
| Less: | | | | | | | | | | | | | | | | | | | | | |
| Cost of goods sold | | | 3,053 | | 2,317 | | | | | 3,181 | | 2,314 | | | | | 3,255 | | 2,255 | | |
| Selling, administrative, engineering and research and development expenses | | | 189 | | 178 | | | | | 210 | | 193 | | | | | 183 | | 176 | | |
| Equity earnings | | | (70) | | (34) | | | | | (59) | | (65) | | | | | (64) | | (43) | | |
| Other segment expenses (income) | | | 20 | | 3 | | | | | 22 | | (7) | | | | | (11) | | 2 | | |
| Segment operating profit | | $392 | $356 | $748 | | $511 | $682 | $1,193 | | $472 | $488 | $960 | |||||||||
| Items excluded from segment operating profit: | | | | | | | | | | | | | | | | | | | | | |
| Retained corporate costs and other | | | | | | | (134) | | | | | | | (224) | | | | | | | (232) |
| Charge for goodwill impairment | | | | | | | | | | | | | | (445) | | | | | | | |
| Restructuring, asset impairment and other charges | | | | | | | (206) | | | | | | | (100) | | | | | | | (53) |
| Equity investment impairment | | | | | | | (25) | | | | | | | | | | | | | | |
| Legacy environmental charge | | | | | | | (11) | | | | | | | | | | | | | | |
| Pension settlement and curtailment charges | | | | | | | (5) | | | | | | | (19) | | | | | | | (20) |
| Gain on sale of divested businesses and miscellaneous assets | | | | | | | 6 | | | | | | | 4 | | | | | | | 55 |
| Gain on sale leasebacks | | | | | | | | | | | | | | | | | | | | | 334 |
| Interest expense, net | | | | | | | (335) | | | | | | | (342) | | | | | | | (239) |
| Earnings before income taxes | | | | | | $38 | | | | | | $67 | | | | | | $805 | |||
| | | | | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · · · · Reportable · Retained · Consoli- | ||||||||||||||||
| · · · · · · · Segment · · Corp Costs · · dated | ||||||||||||||||
| · · Americas · · Europe · · Totals · · and Other · · Totals | ||||||||||||||||
| Total assets: | | | | | | | | | | | | | | | | |
| 2024 | | $4,646 | | $3,534 | | $8,180 | | $474 | | $8,654 | | |||||
| 2023 | | | 5,218 | | | 3,949 | | | 9,167 | | | 502 | | | 9,669 | |
| 2022 | | | 5,109 | | | 3,392 | | | 8,501 | | | 560 | | | 9,061 | |
| Equity investments: | | | | | | | | | | | | | | | | |
| 2024 | | $446 | | $182 | | $628 | | $33 | | $661 | | |||||
| 2023 | | | 490 | | | 193 | | | 683 | | | 60 | | | 743 | |
| 2022 | | | 488 | | | 146 | | | 634 | | | 61 | | | 695 | |
| Equity earnings: | | | | | | | | | | | | | | | | |
| 2024 | | $70 | | $34 | | $104 | | $(25) | | $79 | | |||||
| 2023 | | | 59 | | | 65 | | | 124 | | | 3 | | | 127 | |
| 2022 | | | 64 | | | 43 | | | 107 | | | — | | | 107 | |
| Capital expenditures: | | | | | | | | | | | | | | | | |
| 2024 | | $354 | | $254 | | $608 | | $9 | | $617 | | |||||
| 2023 | | | 459 | | | 221 | | | 680 | | | 8 | | | 688 | |
| 2022 | | | 339 | | | 192 | | | 531 | | | 8 | | | 539 | |
| Depreciation and amortization expense: | | | | | | | | | | | | | | | | |
| 2024 | | $296 | | $169 | | $465 | | $21 | | $486 | | |||||
| 2023 | | | 296 | | | 166 | | | 462 | | | 21 | | | 483 | |
| 2022 | | | 278 | | | 152 | | | 430 | | | 24 | | | 454 | |
The Company’s tangible long-lived assets, including property, plant and equipment and operating lease right-of-use assets, by geographic region are as follows:
| · · · · · · · · · · | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| · U.S. · Non-U.S. · Total | |||||||||
| 2024 | | $927 | | $2,570 | | $3,497 | | ||
| 2023 | | 845 | | | 2,930 | | | 3,775 | |
| 2022 | | 766 | | | 2,421 | | | 3,187 | |
The Company’s net sales by geographic region are as follows:
| · · · · · · · · · · | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| · U.S. · Non-U.S. · Total | |||||||||
| 2024 | | $1,686 | | $4,845 | | $6,531 | | ||
| 2023 | | 1,828 | | | 5,277 | | | 7,105 | |
| 2022 | | 1,941 | | | 4,915 | | | 6,856 | |
Operations outside the U.S. that accounted for 10% or more of consolidated net sales were in France (2024-11%, 2023-11%, 2022-11%), Italy (2024-13%, 2023-13%, 2022-12%), and Mexico (2024-14%, 2023-14%, 2022 -13%).
3. Revenue
Revenue is recognized at a point in time when obligations under the terms of the Company’s contracts and related purchase orders with its customers are satisfied. This occurs with the transfer of control of glass containers, which primarily takes place when products are shipped from the Company’s manufacturing or warehousing facilities to the customer. Revenue is measured as the amount of consideration the Company
expects to receive in exchange for transferring goods, which includes estimated provisions for rebates, discounts, returns and allowances. Amounts billed to customers related to shipping and handling or other pass-through items are included in net sales in the Consolidated Results of Operations. Sales, value-added, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue. The Company’s payment terms are based on customary business practices and can vary by customer type. The term between invoicing and when payment is due is not significant. Also, the Company elected to account for shipping and handling costs as a fulfillment cost at the time of shipment.
For the years ended December 31, 2024 and 2023, the Company had no material bad debt expense and there were no material contract assets, contract liabilities or deferred contract costs recorded on the Consolidated Balance Sheet. For the years ended December 31, 2024, 2023 and 2022, revenue recognized from prior periods (for example, due to changes in transaction price) was not material. The Company recognized revenue of approximately $40 million and $42 million from sales to affiliates in 2024 and 2023, respectively.
The following table for the year ended December 31, 2024 disaggregates the Company’s revenue by customer end use:
| | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · Americas · · Europe · · Total · · · | ||||||||||||
| | | | | | | | | | | | | |
| Alcoholic beverages (beer, wine, spirits) | $2,000 | $2,041 | $4,041 | | | | ||||||
| Food and other | | 872 | | 480 | | 1,352 | | | | |||
| Non-alcoholic beverages | | 712 | | 299 | | 1,011 | | | | |||
| Reportable segment totals | | $3,584 | | $2,820 | | $6,404 | | | | |||
| Other | | | | | | | | 127 | | | | |
| Net sales | | | | | | | $6,531 | | | | ||
The following table for the year ended December 31, 2023 disaggregates the Company’s revenue by customer end use:
| | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · Americas · · Europe · · Total · · · | ||||||||||||
| | | | | | | | | | | | | |
| Alcoholic beverages (beer, wine, spirits) | $2,268 | $2,320 | $4,588 | | | | ||||||
| Food and other | | 865 | | 508 | | 1,373 | | | | |||
| Non-alcoholic beverages | | 732 | | 289 | | 1,021 | | | | |||
| Reportable segment totals | | $3,865 | | $3,117 | | $6,982 | | | | |||
| Other | | | | | | | | 123 | | | | |
| Net sales | | | | | | | $7,105 | | | | ||
The following table for the year ended December 31, 2022 disaggregates the Company’s revenue by customer end use:
| | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · Americas · · Europe · · Total · · | ||||||||||||
| | | | | | | | | | | | | |
| Alcoholic beverages (beer, wine, spirits) | $2,367 | $2,169 | $4,536 | | | | ||||||
| Food and other | | 832 | | 467 | | 1,299 | | | | |||
| Non-alcoholic beverages | | 636 | | 242 | | 878 | | | | |||
| Reportable segment totals | | $3,835 | | $2,878 | | $6,713 | | | | |||
| Other | | | | | | | | 143 | | | | |
| Net sales | | | | | | | $6,856 | | | | ||
4. Credit Losses
The Company is exposed to credit losses primarily through its sales of glass containers to customers. The Company’s trade receivables from customers are due within one year or less. The Company assesses each customer’s ability to pay for the glass containers it sells to them by conducting a credit review. The credit review considers the expected billing exposure and timing for payment and the customer’s established credit rating or the Company’s assessment of the customer’s creditworthiness, based on an analysis of their financial statements when a credit rating is not available. The Company also considers contract terms and conditions, country and political risk, and business strategy in its evaluation. A credit limit is established for each customer based on the outcome of this review. The Company may require collateralized asset support or a prepayment to mitigate credit risk. The Company monitors its ongoing credit exposure through the active review of customer balances against contract terms and due dates, including timely account reconciliation, dispute resolution and payment confirmation. The Company may employ collection agencies and legal counsel to pursue the recovery of defaulted receivables.
At December 31, 2024 and 2023, the Company reported $572 million and $671 million of accounts receivable, respectively, net of allowances of $30 million and $30 million, respectively. Changes in the allowance were not material for the years ended December 31, 2024 or 2023.
5. Inventories
Major classes of inventory are as follows:
| · · · · · · · | |||||
|---|---|---|---|---|---|
| · 2024 · 2023 | |||||
| Finished goods | | $745 | | $868 | |
| Raw materials | | 169 | | 151 | |
| Operating supplies | | 49 | | 52 | |
| | | $963 | | $1,071 | |
6. Equity Investments
At December 31, 2024, the Company’s ownership percentage in affiliates includes:
| · · · · · · | |||||
|---|---|---|---|---|---|
| · · O-I Ownership · · | |||||
| Affiliates · Percentage · Business Type | |||||
| Empresas Comegua S.A. | | 49.7% | | Glass container manufacturer | |
| BJC O-I Glass Pte. Ltd. | | 50% | | Glass container manufacturer | |
| CO Vidrieria SARL ("COV") | | 50% | | Glass container manufacturer | |
| Rocky Mountain Bottle Company | | 50% | | Glass container manufacturer | |
| Vetrerie Meridionali SpA ("VeMe") | | 50% | | Glass container manufacturer | |
| Vetri Speciali SpA | | 50% | | Specialty glass manufacturer | |
Summarized information pertaining to the Company’s equity affiliates follows:
| · · · · · · · · · · | |||||||
|---|---|---|---|---|---|---|---|
| · 2024 · 2023 · 2022 | |||||||
| Equity in earnings: · · · · · · · · · · | |||||||
| Non-U.S. | | $75 | | $121 | | $101 | |
| U.S. | | 4 | | 6 | | 6 | |
| Total | | $79 | | $127 | | $107 | |
| Dividends received | | $101 | | $116 | | $71 | |
In 2024, the Company determined that the current fair value of one of its non-U.S. equity investments (a small glass container manufacturer reported in the non-reportable Retained corporate costs and other category) was less than its carrying value and that it was other-than-temporarily impaired. As such, the Company recorded an impairment charge of approximately$25 million to the equity earnings line in its Consolidated Results of Operations to reduce its carrying value down to its estimated fair value. Subsequent to the impairment charge, the remaining carrying value of this equity investment was approximately$5 million. The Company classified the significant assumptions that were utilized in a third-party market quote to determine the fair value of the impaired assets as Level 3 in the fair value hierarchy as set forth in the general accounting principles for fair value measurements.
Summarized combined financial information for equity affiliates is as follows (unaudited):
| · · · · · · · | |||||
|---|---|---|---|---|---|
| · 2024 · 2023 | |||||
| At end of year: · · · · · · · | |||||
| Current assets | | $698 | | $695 | |
| Non-current assets | | 1,405 | | 1,458 | |
| Total assets | | 2,103 | | 2,153 | |
| Current liabilities | | 502 | | 496 | |
| Other liabilities and deferred items | | 230 | | 221 | |
| Total liabilities and deferred items | | 732 | | 717 | |
| Net assets | | $1,371 | | $1,436 | |
| · · · · · · · · · · | |||||||
|---|---|---|---|---|---|---|---|
| For the year: · 2024 · 2023 · 2022 | |||||||
| Net sales | | $1,207 | | $1,274 | | $1,328 | |
| Gross profit | | $344 | | $351 | | $348 | |
| Net earnings | | $213 | | $236 | | $232 | |
Based on an evaluation of each of the Company’s equity investments for the three years ending December 31, 2024, no investments exceeded the significant subsidiary thresholds per Rule 3-09 of Regulation S-X. As such, separate financial statements for the Company’s equity investments are not required to be filed with the Securities and Exchange Commission.
The Company made purchases of approximately $121 million and $126 million from equity affiliates in 2024 and 2023, respectively, and owed approximately $77 million and $81 million to equity affiliates as of December 31, 2024 and 2023, respectively.
7. Goodwill and Intangible Assets
Goodwill
The changes in the carrying amount of goodwill for the years ended December 31, 2024, 2023, and 2022 are as follows:
| | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|
| · · · · · | |||||||||
| · · Europe · · Americas · · Total | |||||||||
| Balance as of January 1, 2022 | | $866 | | $974 | | $1,840 | |||
| Translation effects | | (48) | | | 21 | | | (27) | |
| Balance as of December 31, 2022 | | | 818 | | | 995 | | | 1,813 |
| Impairment | | | | | | (445) | | | (445) |
| Translation effects | | 30 | | | 75 | | | 105 | |
| Balance as of December 31, 2023 | | | 848 | | | 625 | | | 1,473 |
| Translation effects | | | (48) | | | (104) | | | (152) |
| Balance as of December 31, 2024 | | $800 | | $521 | | $1,321 | |||
Goodwill is tested for impairment annually as of October 1 (or more frequently if impairment indicators arise) by comparing the fair value of each reporting unit, which is determined by computing the business enterprise value ("BEV"), with its carrying value. The BEV is computed based on estimated future cash flows, discounted at the weighted average cost of capital of a hypothetical third-party buyer. If the BEV is less than the carrying value for any reporting unit, then any excess of the carrying value over the BEV will be recorded as an impairment loss. The calculations of the BEV of the Company’s reporting units were determined based on valuation techniques using the best available information of significant unobservable inputs, primarily revenue growth, earnings before interest, taxes, depreciation and amortization (EBITDA) margin, and the weighted average cost of capital, and are classified as Level 3 in the fair value hierarchy.
During the fourth quarter of 2024, the Company completed its annual impairment testing and determined that noimpairment existed. However, there can be no assurance that anticipated financial results will be achieved and the goodwill balances remain susceptible to future impairment charges. If the Company’s projected future cash flows were lower, or if the assumed weighted average cost of capital were higher, the testing performed in the fourth quarter of 2024 may have indicated an impairment of the goodwill related to one or more of the Company’s reporting units. Any impairment charges that the Company may take in the future could be material to its consolidated results of operations and financial condition.
During the time subsequent to the annual evaluation, and at December 31, 2024, the Company considered whether any events and/or changes in circumstances had resulted in the likelihood that the goodwill of any of its reporting units may have been impaired and has determined that no such events have occurred.
During the fourth quarter of 2023, the Company completed its annual impairment testing and determined that the goodwill balance on its North America reporting unit was fully impaired. The primary driver of this impairment was management’s update to its long-range plan, which indicated lower estimated future cash flows for its North America reporting unit (in the Americas segment) as compared to the projections used in the prior goodwill impairment test performed as of October 1, 2022. The Company’s business in North America has experienced declining shipments to its alcoholic beverage customers, especially in the second half of 2023, and this trend was likely to continue for the foreseeable future. As a result, the Company recorded a non-cash impairment charge of$445 million in the fourth quarter of 2023, which was equal to the remaining goodwill balance on its North America reporting unit. Goodwill related to the Company’s other reporting units was determined to not be impaired as a result of the 2023 impairment test.
Goodwill for the Americas segment is net of accumulated impairment losses of $1,040 million as of December 31, 2024 and 2023.
Intangible Assets
Customer list intangible assets are amortized using the accelerated amortization method over their 20 year lives. Net intangible asset values were $198 million and $254 million, which included accumulated amortization of $345 million and $316 million, for the years ended December 31, 2024 and 2023, respectively. Amortization expense for intangible assets was $29 million, $32 million and $33 million for the years ended December 31, 2024, 2023, and 2022, respectively. Estimated amortization related to intangible assets through 2029 is as follows: 2025, $24 million; 2026, $22 million; 2027, $20 million; 2028, $19 million and 2029, $18 million. No impairment existed on these assets at December 31, 2024.
The Company has determined that the fair value measurements related to the customer list intangible assets are based on significant unobservable inputs and are classified as Level 3 in the fair value hierarchy.
8. Other Assets
Other assets (noncurrent) consist of the following at December 31, 2024 and 2023:
| | | | | | | | |
|---|---|---|---|---|---|---|---|
| · 2024 · 2023 | |||||||
| Right of use lease assets | | $201 | | $220 | | ||
| Repair parts | | | 151 | | | 154 | |
| Deferred tax assets | | | 79 | | | 107 | |
| Deferred returnable packaging costs | | 88 | | 103 | | ||
| Capitalized software | | 37 | | 42 | | ||
| Value added taxes | | 14 | | 17 | | ||
| Other | | 38 | | 51 | | ||
| | | $608 | | $694 | | ||
Capitalized software includes costs related to the acquisition and development of internal-use software. These costs are amortized over the estimated useful life of the software. Amortization expense for capitalized software was $7 million, $9 million and $10 million for 2024, 2023 and 2022, respectively. Estimated amortization related to capitalized software through 2029 is as follows: 2025, $7 million; 2026, $7 million; 2027, $6 million; 2028, $6 million and 2029, $5 million.
9**. Derivative Instruments**
The Company has certain derivative assets and liabilities which consist of natural gas forwards and collars, foreign exchange option and forward contracts, interest rate swaps and cross-currency swaps. The valuation of these instruments is determined primarily using the income approach, including discounted cash flow analysis on the expected cash flows of each derivative. Natural gas prices, foreign exchange rates and interest rates are the significant inputs into the valuation models. The Company also evaluates counterparty risk in determining fair values. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves and implied volatilities. Estimates of the fair value of foreign currency and commodity derivative instruments are determined using exchange traded prices and rates. The fair values of interest rate swaps are determined using the market standard methodology of netting the discounted future fixed cash receipts (or payments) and the discounted expected variable cash payments (or receipts). The variable cash payments (or receipts) are based on an expectation of future interest rates (forward curves) derived from observable market interest rate curves. These inputs are observable in active markets over the terms of the instruments the Company holds, and accordingly, the Company classifies its derivative assets and liabilities as Level 2 in the hierarchy.
Commodity Forward Contracts and Collars Designated as Cash Flow Hedges
The Company has entered into commodity forward contracts and collars related to forecasted natural gas requirements, the objective of which are to limit the effects of fluctuations in future market prices of natural gas and the related volatility in cash flows.
An unrecognized loss of$2 and $0 million at December 31, 2024 and December 31, 2023, respectively, related to the commodity forward contracts and collars was included in Accumulated other comprehensive income (loss) (“Accumulated OCI”), and will be reclassified into earnings over the next 12 months.
Cash Flow Hedges of Foreign Exchange Risk
The Company has variable-interest rate borrowings denominated in currencies other than the functional currency of the borrowing subsidiaries. As a result, the Company is exposed to fluctuations in the currency of the borrowing against the subsidiaries’ functional currency. In addition, one of the Company’s non-U.S. dollar-functional-currency subsidiaries purchases a raw material in the normal course of business for use in glass container production that is priced in U.S. dollars. Such purchases expose the Company to exchange rate fluctuations. The Company uses derivatives to manage these exposures and designates these derivatives as cash flow hedges of foreign exchange risk.
No unrecognized gains related to cross-currency swaps were included in Accumulated OCI at December 31, 2024 and December 31, 2023.
Fair Value Hedges of Foreign Exchange Risk
The Company has fixed and variable interest rate borrowings denominated in currencies other than the functional currency of the borrowing subsidiaries. As a result, the Company is exposed to fluctuations in the currency of the borrowing against the subsidiaries’ functional currency. The Company uses derivatives to manage these exposures and designates these derivatives as fair value hedges of foreign exchange risk. Approximately $12 million and $2 million of the components were excluded from the assessment of effectiveness and are included in Accumulated OCI at December 31, 2024 and December 31, 2023, respectively.
Interest Rate Swaps Designated as Fair Value Hedges
The Company enters into interest rate swaps in order to maintain a capital structure containing targeted amounts of fixed and floating-rate debt and manage interest rate risk. The Company’s fixed-to-variable interest rate swaps are accounted for as fair value hedges. The relevant terms of the swap agreements match the corresponding terms of the notes, and therefore, there is no hedge ineffectiveness. The Company recorded the net of the fair market values of the swaps as a long-term liability and short-term asset along with a corresponding net decrease in the carrying value of the hedged debt.
In 2023, the Company terminated interest rate swaps with a notional amount of €725 million as a result of debt refinancing activity. This resulted in a cash outflow of approximately $40 million in the financing activities section of the Consolidated Cash Flows.
Net Investment Hedges
The Company is exposed to fluctuations in foreign exchange rates on investments it holds in non-U.S. subsidiaries and uses cross-currency swaps to partially hedge this exposure.
Foreign Exchange Derivative Contracts Not Designated as Hedging Instruments
The Company uses short-term forward exchange or option agreements to purchase foreign currencies at set rates in the future. These agreements are used to limit exposure to fluctuations in foreign currency exchange rates for significant planned purchases of fixed assets or commodities that are denominated in currencies other than the subsidiaries’ functional currency. The Company also uses foreign exchange agreements to offset the foreign currency exchange rate risk for receivables and payables, including intercompany receivables, payables, and loans, not denominated in, or indexed to, their functional currencies.
In 2024, the Company paid approximately $29 million to settle related hedges and recognized these payments in the cash flows from investing activities section of the Consolidated Cash Flows.
Balance Sheet Classification
The following table shows the amount and classification (as noted above) of the Company’s derivatives at December 31, 2024 and 2023:
| | | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · · Fair Value of · | ||||||||||||||
| · · · Hedge Assets · · Hedge Liabilities · | ||||||||||||||
| · · 2024 · · 2023 · · 2024 · · 2023 · | ||||||||||||||
| Derivatives designated as hedging instruments: · · · · · · · · | ||||||||||||||
| Commodity forward contracts and collars (a) | | | $— | | $— | | $6 | | $14 | | ||||
| Fair value hedges of foreign exchange risk (b) | | | | 8 | | | 4 | | | 69 | | | 111 | |
| Net investment hedges (c) | | | | 7 | | | 4 | | | 29 | | | 56 | |
| Total derivatives accounted for as hedges | | | $15 | | $8 | | $104 | | $181 | | ||||
| Derivatives not designated as hedges: | | | | | | | | | | | | | | |
| Foreign exchange derivative contracts (d) | | | | 2 | | | 5 | | | 10 | | | 9 | |
| Total derivatives | | | $17 | | $13 | | $114 | | $190 | | ||||
| | | | | | | | | | | | | | | |
| Current | | | $17 | | $13 | | $12 | | $17 | | ||||
| Noncurrent | | | | | | | | | | 102 | | | 173 | |
| Total derivatives | | | $17 | | $13 | | $114 | | $190 | | ||||
| (a) | The notional amount of the commodity forward contracts and collars was approximately 28 million British Thermal Units (“BTUs”) and 38 million BTUs at December 31, 2024 and December 31, 2023, respectively. The maximum maturity dates are in 2027 at December 31, 2024 and December 31, 2023. |
|---|
| (b) | The notional amounts of the fair value hedges of foreign exchange risk were $816 million and $833 million at December 31, 2024 and December 31, 2023, respectively. The maximum maturity dates were in 2030 at December 31, 2024 and December 31, 2023. |
|---|
| (c) | The notional amounts of the net investment hedges were €483 million and €483 million at December 31, 2024 and December 31, 2023, respectively. The maximum maturity dates are in 2026 at December 31, 2024 and December 31, 2023. |
|---|
| (d) | The notional amounts of the foreign exchange derivative contracts were $680 million and $407 million at December 31, 2024 and December 31, 2023, respectively. The maximum maturity dates are in 2025 at December 31, 2024 and 2024 at December 31, 2023. |
|---|
The effects of derivative instruments on the Company’s Consolidated Results of Operations and Comprehensive Income (Loss) for OCI for the years ended December 31, 2024, 2023 and 2022 are as follows:
| | | | | | | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · Gain (Loss) Recognized in OCI (Effective Portion) · · Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) (1) | ||||||||||||||||||
| Derivatives designated as hedging instruments: · 2024 · · 2023 · · 2022 · · 2024 · · 2023 · · 2022 | ||||||||||||||||||
| Cash Flow Hedges · · · · · · · · · · · · | ||||||||||||||||||
| Commodity forward contracts and collars (a) | | $(3) | | $(27) | | $(1) | | $(10) | | $(21) | | $6 | ||||||
| Cash flow hedges of foreign exchange risk (b) | | | | | | (3) | | | 14 | | | | | | (4) | | | 15 |
| Net Investment Hedges | | | | | | | | | | | | | | | | | | |
| Net Investment Hedges | | | 36 | | | (21) | | | 30 | | | 6 | | | 5 | | | 6 |
| | | $33 | | $(51) | | $43 | | $(4) | | $(20) | | $27 | ||||||
| | | | | | | | | | | | | | | | | | | |
| | | Amount of Loss Recognized in Other income (expense), net | | | | | | | | | | |||||||
| Derivatives not designated as hedges: | 2024 | | 2023 | | 2022 | | | | | | | | | | ||||
| Foreign exchange derivative contracts | $(36) | $(12) | $(20) | | | | | | | | | | ||||||
| | | | | | | | | | | | | | | | | | | |
| (1) Gains and losses reclassified from accumulated OCI and recognized in income are recorded to (a) cost of goods sold or (b) other income (expense), net | ||||||||||||||||||
10**. Restructuring**
The Company continually reviews its manufacturing footprint and operating cost structure and may decide to close operations or reduce headcount to gain efficiencies, integrate acquired operations, reduce future expenses and address other market factors. The Company incurs costs associated with these actions including employee severance and benefits, other exit costs such as those related to contract terminations, and asset impairment charges. The Company also may incur other costs related to closed facilities including clean-up, dismantling and preparation for sale or other disposition.
The Company accounts for restructuring and other costs under applicable provisions of generally accepted accounting principles. Charges for employee severance and related benefits are generally accrued based on contractual arrangements with employees or their representatives. Other exit costs are accrued based on the estimated cost to settle related contractual arrangements. Estimated environmental remediation costs are accrued when specific claims have been received or are probable of being received.
The Company’s decisions to curtail selected production capacity have resulted in write-downs of certain long-lived assets to the extent their carrying amounts exceeded fair value or fair value less cost to sell. The Company classified the significant assumptions used to determine the fair value of the impaired assets in the period that the measurement was taken as Level 3 (third-party appraisal, where applicable) in the fair value hierarchy as set forth in the general accounting principles for fair value measurements. For the asset impairments recorded through December 31, 2024 and December 31, 2023, the remaining carrying value of the impaired assets was$0.
When a decision is made to take restructuring actions, the Company manages and accounts for them programmatically apart from the ongoing operations of the business. Information related to major programs is presented separately while minor initiatives are presented on a combined basis.
For 2024, the Company’s only major restructuring program was the Fit to Win initiative, which is expected to reduce redundant production capacity and begin to optimize the network, as well as streamline other cost areas, such as selling, general and administrative expenses. Details regarding charges, payments and other changes to the Fit to Win restructuring accruals are presented in the table below. This major restructuring program is expected to last at least through 2025 and management does not yet have an estimate for the total restructuring charges expected to be incurred with this program, however, the total charges are expected to be material. For 2023, no major restructuring programs were in effect.
For the year ended December 31, 2024, the Company recorded restructuring and other charges of approximately$208 million to Other income (expense), net ($206 million) and Equity earnings ($2 million) in the Consolidated Results of Operations, of which$201 million related to the Fit to Win program. These charges consisted of employee costs, such as severance and benefit-related costs, write-down of assets and other exit costs in the Americas segment ($79 million), Europe segment ($115 million) and Retained corporate costs and other ($14 million). As of December 31, 2024, the Company has incurred cumulative charges of$201 million related to the Fit to Win program. Additional restructuring charges are expected in future quarters when management completes their assessment to reduce redundant production capacity. The Company expects that the majority of the remaining cash expenditures related to the accrued employee and other exit costs will be paid out over the next several years.
For the year ended December 31, 2023, the Company implemented several discrete restructuring initiatives and recorded restructuring and other charges of $97 million to Other income (expense), net in the Consolidated Results of Operations. These charges consisted of employee costs, such as severance and benefit-related costs, write-down of assets and other exit costs in the Americas segment ($89 million), Europe segment ($6 million) and Retained corporate costs and other ($2 million). These restructuring charges were discrete actions and are expected to approximate the total cumulative costs for those actions as no significant additional costs are expected to be incurred. The Company expects that the majority of the remaining cash expenditures related to the accrued employee costs will be paid out over the next several years.
The following table presents information related to restructuring, asset impairment and other costs related to closed facilities from January 1, 2023 through December 31, 2024:
| | | | | | | | | | | | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · Fit to Win program · · · Other Restructuring · · · | |||||||||||||||||||||||
| · · Employee · · Asset · · Other · · · Employee · · Asset · · Other · · Total · | |||||||||||||||||||||||
| · Costs · · Impairment · · Exit Costs · · · Costs · · Impairment · · Exit Costs · Restructuring | |||||||||||||||||||||||
| Balance at January 1, 2023 | | $— | | $— | | $— | | | $17 | | $— | | $10 | | $27 | | |||||||
| Charges | | | | | | | | | | | 32 | | | 55 | | | 10 | | | 97 | | ||
| Write-down of assets to net realizable value | | | | | | | | | | | | | | | | (55) | | | | | | (55) | |
| Net cash paid, principally severance and related benefits | | | | | | | | | | | | | (20) | | | | | | (6) | | | (26) | |
| Other, including foreign exchange translation | | | | | | | | | | | | | (2) | | | | | | (2) | | | (4) | |
| Balance at December 31, 2023 | | $— | | $— | | $— | | | $27 | | $— | | $12 | | $39 | | |||||||
| Charges | | 73 | | | 109 | | | 19 | | | 1 | | | 4 | | | 2 | | 208 | | |||
| Write-down of assets to net realizable value | | | | | | (109) | | | | | | | | | | (4) | | | | | (113) | | |
| Net cash paid, principally severance and related benefits | | | (14) | | | | | | (1) | | | | (19) | | | | | | (7) | | | (41) | |
| Other, including foreign exchange translation | | | (8) | | | | | | | | | | (2) | | | | | | (3) | | (13) | | |
| Balance at December 31, 2024 | | $51 | | $— | | $18 | | | $7 | | $— | | $4 | | $80 | ||||||||
11. Pension Benefit Plans and Other Postretirement Benefits
Pension Benefit Plans
The Company has defined benefit pension plans covering a substantial number of employees located in the United States and several other non-U.S. jurisdictions. Benefits generally are based on compensation for salaried employees and on length of service for hourly employees. The Company’s policy is to fund pension plans such that sufficient assets will be available to meet future benefit requirements. The Company’s defined benefit pension plans use a December 31 measurement date.
The changes in the pension benefit obligations for the year are as follows:
| | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · U.S. · · Non-U.S. | |||||||||||||
| · 2024 · 2023 · 2024 · 2023 | |||||||||||||
| Obligations at beginning of year | | $866 | | $860 | | $727 | | $669 | | ||||
| Change in benefit obligations: | | | | | | | | | | | | | |
| Service cost | | 6 | | 6 | | 9 | | 8 | | ||||
| Interest cost | | 43 | | 45 | | 35 | | 38 | | ||||
| Actuarial (gain) loss | | | (45) | | | 23 | | | (56) | | | 25 | |
| Settlements | | | | | | | | (15) | | | (31) | | |
| Curtailments | | | | | | | | (2) | | | 13 | | |
| Benefit payments | | (78) | | (70) | | (41) | | (41) | | ||||
| Other | | | | | | 2 | | | | | | 1 | |
| Foreign currency translation | | | | | | | | (42) | | 45 | | ||
| Net change in benefit obligations | | (73) | | 6 | | (112) | | 58 | | ||||
| Obligations at end of year | | $793 | | $866 | | $615 | | $727 | | ||||
The changes in the fair value of the pension plans’ assets for the year are as follows:
| | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · U.S. · · Non-U.S. | |||||||||||||
| · 2024 · 2023 · 2024 · 2023 | |||||||||||||
| Fair value at beginning of year | | $837 | | $812 | | $564 | | $547 | | ||||
| Change in fair value: | | | | | | | | | | | | | |
| Actual gain (loss) on plan assets | | 30 | | 94 | | (12) | | 27 | | ||||
| Benefit payments | | (78) | | (70) | | (41) | | (41) | | ||||
| Employer contributions | | 5 | | 1 | | 27 | | 31 | | ||||
| Participant contributions | | | | | | | | 1 | | | | ||
| Settlements | | | | | | | | | (15) | | | (31) | |
| Foreign currency translation | | | | | | | | (19) | | 31 | | ||
| Other | | | | | | | | | | | | ||
| Net change in fair value of assets | | (43) | | 25 | | (59) | | 17 | | ||||
| Fair value at end of year | | $794 | | $837 | | $505 | | $564 | | ||||
The Company recognizes the funded status of each pension benefit plan on the Consolidated Balance Sheet. The funded status of each plan is measured as the difference between the fair value of plan assets and actuarially calculated benefit obligations as of the balance sheet date. Actuarial gains and losses are primarily related to changes in asset performance and in discount rates, and are accumulated in Accumulated Other Comprehensive Loss. The portion of accumulated actuarial gains and losses of each plan that exceeds 10% of the greater of that
plan’s assets or projected benefit obligation is amortized to income on a straight-line basis over the average remaining service period of employees still accruing benefits or the expected life of participants not accruing benefits if all, or almost all, of the plan’s participants are no longer accruing benefits.
The funded status of the pension plans at year end is as follows:
| | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · U.S. · · Non-U.S. | |||||||||||||
| · · 2024 · · 2023 · · 2024 · · 2023 | |||||||||||||
| Plan assets at fair value | $794 | $837 | $505 | $564 | | ||||||||
| Projected benefit obligations | | 793 | | 866 | | 615 | | 727 | | ||||
| Plan assets less than projected benefit obligations | | 1 | | (29) | | (110) | | (163) | | ||||
| Items not yet recognized in pension expense: | | | | | | | | | | | | | |
| Actuarial loss | | 321 | | 357 | | 283 | | 320 | | ||||
| Prior service cost | | | | | | 9 | | 9 | | ||||
| | | 321 | | 357 | | 292 | | 329 | | ||||
| Net amount recognized | | $322 | | $328 | | $182 | | $166 | | ||||
The net amount recognized is included in the Consolidated Balance Sheets at December 31, 2024 and 2023 as follows:
| · · · · · · · · · · · · · | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| · · U.S. · · Non-U.S. | ||||||||||
| · 2024 · 2023 · 2024 · 2023 | ||||||||||
| Pension assets | | $8 | | $ | | | $84 | | $66 | |
| Current pension liability, included with other accrued liabilities | | (1) | | (2) | | (7) | | (8) | | |
| Pension benefits | | (6) | | (27) | | (187) | | (221) | | |
| Accumulated other comprehensive loss | | 321 | | 357 | | 292 | | 329 | | |
| Net amount recognized | | $322 | | $328 | | $182 | | $166 | | |
The following changes in plan assets and benefit obligations were recognized in Accumulated Other Comprehensive Loss at December 31, 2024 and 2023 as follows:
| | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · U.S. · · Non-U.S. | |||||||||||||
| · 2024 · 2023 · 2024 · 2023 | |||||||||||||
| Current year actuarial (gain) loss | | $(22) | | $(15) | | $(14) | | $38 | | ||||
| Amortization of actuarial loss | | (14) | | (9) | | (10) | | (9) | | ||||
| Settlement | | | | | | | | | (4) | | | (6) | |
| Curtailment | | | | | | | | | | | | (13) | |
| Other | | | | | | | | | | | | | |
| Foreign currency translation | | | | | | | | (9) | | 21 | | ||
| | | $(36) | | $(24) | | $(37) | | $31 | | ||||
The components of the net pension expense for the year are as follows:
| | | | | | | | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · U.S. · · Non-U.S. | |||||||||||||||||||
| · · 2024 · · 2023 · · 2022 · · 2024 · · 2023 · · 2022 | |||||||||||||||||||
| Service cost | $6 | $6 | $13 | $9 | $8 | $10 | | ||||||||||||
| Interest cost | | 43 | | 45 | | 35 | | 35 | | 38 | | 24 | | ||||||
| Expected asset return | | (53) | | (55) | | (61) | | (32) | | (30) | | (36) | | ||||||
| Amortization: | | | | | | | | | | | | | | | | | | | |
| Actuarial loss | | 14 | | 9 | | 40 | | 10 | | 9 | | 9 | | ||||||
| Net expense | | $10 | | $5 | | $27 | | $22 | | $25 | | $7 | | ||||||
In addition to the above net pension expense, in 2024, 2023, and 2022, the Company also settled a portion of its pension obligations in the U.S., Canada and Mexico, resulting in settlement charges of approximately $5 million, $6 million, and $20 million, respectively. In 2023, the Company also recorded a curtailment charge of$13 million primarily related to the reduction of workforce in Mexico. In 2022, settlement charges related to lump sum payments directly to plan participants.
The components of pension expense, other than the service cost component, as well as pension curtailment and settlement charges are included in Other income (expense), net in the Consolidated Results of Operations.
The following information is for plans with projected and accumulated benefit obligations in excess of the fair value of plan assets at year-end:
| · · · · · · · · · · · · · · · · · · · · · · · · · | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · Projected Benefit Obligation Exceeds · · Accumulated Benefit Obligation Exceeds | |||||||||||||||||
| · · the Fair Value of Plan Assets · · the Fair Value of Plan Assets | |||||||||||||||||
| · · U.S. · · Non-U.S. · · U.S. · · Non-U.S. | |||||||||||||||||
| · 2024 · · 2023 · 2024 · · 2023 · 2024 · · 2023 · 2024 · · 2023 · | |||||||||||||||||
| Projected benefit obligations | | $257 | | $866 | | $227 | | $282 | | $257 | | $866 | | $227 | | $282 | |
| Accumulated benefit obligation | | 257 | | 866 | | 199 | | 247 | | 257 | | 866 | | 199 | | 247 | |
| Fair value of plan assets | | 250 | | 837 | | 32 | | 53 | | 250 | | 837 | | 32 | | 53 | |
The accumulated benefit obligation for all defined benefit pension plans was $1,379 million and $1,556 million at December 31, 2024 and 2023, respectively.
The weighted average assumptions used to determine benefit obligations are as follows:
| · · · · · · · · · | ||||||
|---|---|---|---|---|---|---|
| · · U.S. · · Non-U.S. | ||||||
| · 2024 · 2023 · 2024 · 2023 | ||||||
| Discount rate | 5.66% | 5.18% | 5.74% | 5.12% | ||
| Rate of compensation increase | N/A | | N/A | | 3.27% | 3.24% |
The weighted average assumptions used to determine net periodic pension costs are as follows:
| · · · · · · · · · · · · · | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| · · U.S. · · Non-U.S. | |||||||||
| · · 2024 · · 2023 · · 2022 · · 2024 · · 2023 · · 2022 | |||||||||
| Discount rate | 5.18% | 5.48% | 2.86% | 5.12% | 5.52% | 2.53% | |||
| Rate of compensation increase | N/A | | N/A | | N/A | | 3.24% | 3.28% | 3.18% |
| Expected long-term rate of return on assets | 5.75% | 5.75% | 5.75% | 5.14% | 4.67% | 4.21% | |||
Future benefits are assumed to increase in a manner consistent with past experience of the plans, which, to the extent benefits are based on compensation, includes assumed salary increases as presented above.
For 2024, the Company’s weighted average expected long-term rate of return on assets was 5.75% for the U.S. plans and 5.14% for the non-U.S. plans. In developing this assumption, the Company considered the Plans’ asset mix and long-term average returns and evaluated input from its third-party pension plan asset consultants, including their review of asset class return expectations.
It is the Company’s policy to invest pension plan assets in a diversified portfolio consisting of an array of asset classes within established target asset allocation ranges. The investment risk of the assets is limited by appropriate diversification both within and between asset classes. Plan assets are primarily invested in a broad mix of domestic and international equities, domestic and international bonds, and real estate, subject to target asset allocation ranges, which may differ by individual plan. The assets are managed with a view to ensuring that sufficient liquidity will be available to meet expected cash flow requirements.
The investment valuation policy of the Company is to value investments at fair value. Equity securities for which market quotations are readily available are valued at the last reported sales price on their principal exchange on valuation date or official close for certain markets. Fixed income investments are valued by an independent pricing service. Investments in registered investment companies or collective pooled funds are valued at their respective net asset values. Short-term investments are stated at amortized cost, which approximates fair value. The fair value of real estate is determined by periodic appraisals.
The assets of the U.S. plans are maintained in a group trust and hold no individual assets other than the investment in the group trust. U.S. pension plan assets are measured at net asset value in the fair value hierarchy and amounted to $794 million and $837 million as of December 31, 2024 and 2023, respectively. In 2024, the group trust assets consisted of approximately 32% equity securities,66% debt securities, and 2% other.
In 2024, the non-U.S. plan assets consisted of approximately 94% debt securities,2% equity securities and 4% diversified funds and other. The following table sets forth by level, within the fair value hierarchy, the Company’s non-U.S. pension plan assets at fair value as of December 31, 2024 and 2023:
| | | | | | | | | | | | | | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · 2024 · · 2023 · | |||||||||||||||||||||||||
| · Level 1 · Level 2 · Level 3 · Total · Level 1 · Level 2 · Level 3 · Total | |||||||||||||||||||||||||
| Cash and cash equivalents | | $12 | | $ | | | $ | | | $12 | | $18 | | $ | | | $ | | | $18 | | ||||
| Debt securities | | | 17 | | | | | | | | | 17 | | | 22 | | | | | | | | | 22 | |
| Diversified funds and other | | | | | | | | | | | | — | | | 23 | | | | | | | | | 23 | |
| Total | | $29 | | $— | | $— | | | | | $63 | | $— | | $— | | | | |||||||
| Investments measured at net asset value | | | | | | | | | | $476 | | | | | | | | | | $501 | |||||
| Total non-U.S. assets at fair value | | | | | | | | | | | $505 | | | | | | | | | | | $564 | | ||
In order to maintain minimum funding requirements, the Company is required to make contributions to its defined benefit pension plans of approximately $17 million in 2025.
The following estimated future benefit payments, which reflect expected future service, as appropriate, are expected to be paid in the years indicated:
| · · · · · · | ||||
|---|---|---|---|---|
| Year(s) · U.S. · Non-U.S. | ||||
| 2025 | | $71 | | $42 |
| 2026 | | 69 | | 43 |
| 2027 | | 68 | | 44 |
| 2028 | | 68 | | 46 |
| 2029 | | 66 | | 48 |
| 2030-2034 | | 306 | | 249 |
The Company also sponsors several defined contribution plans for all salaried and hourly U.S. employees, and employees in Canada, the United Kingdom, and the Netherlands. Participants’ contributions are based on their compensation. The Company matches contributions of participants, up to various limits, in substantially all plans. Company contributions to these plans amounted to$34 million in 2024, $35 million in 2023, and $32 million in 2022.
Postretirement Benefits Other Than Pensions
The Company provides retiree health care and life insurance benefits covering certain U.S. salaried and hourly employees, and substantially all employees in Canada. Benefits provided by the Company for hourly retirees are determined by collective bargaining. Employees are generally eligible for benefits upon retirement and completion of a specified number of years of creditable service. The Company uses a December 31 measurement date to measure its postretirement benefit obligations.
The changes in the postretirement benefit obligations for the year are as follows:
| | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · U.S. · · Non-U.S. | |||||||||||||
| · 2024 · 2023 · 2024 · 2023 | |||||||||||||
| Obligations at beginning of year | | $21 | | $22 | | $50 | | $45 | | ||||
| Change in benefit obligations: | | | | | | | | | | | | | |
| Service cost | | | | | | 1 | | 1 | | ||||
| Interest cost | | 1 | | 1 | | 2 | | 2 | | ||||
| Actuarial (gain) loss | | (1) | | | | (1) | | 3 | | ||||
| Benefit payments | | (2) | | (2) | | (2) | | (2) | | ||||
| Foreign currency translation | | | | | | | | (4) | | 1 | | ||
| Net change in benefit obligations | | (2) | | (1) | | (4) | | 5 | | ||||
| Obligations at end of year | | $19 | | $21 | | $46 | | $50 | | ||||
The actuarial (gain) loss for the Company’s postretirement benefit obligations in 2024 and 2023 was primarily related to changes in discount rates.
The funded status of the postretirement benefit plans at year end is as follows:
| | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · U.S. · · Non-U.S. | |||||||||||||
| · 2024 · 2023 · 2024 · 2023 | |||||||||||||
| Postretirement benefit obligations | | $(19) | | $(21) | | $(46) | | $(50) | | ||||
| Items not yet recognized in net postretirement benefit cost: | | | | | | | | | | | | | |
| Actuarial gain | | | (29) | | | (20) | | | (30) | | | (35) | |
| Prior service credit | | | | (9) | | | | | | ||||
| | | (29) | | (29) | | (30) | | (35) | | ||||
| Net amount recognized | | $(48) | | $(50) | | $(76) | | $(85) | | ||||
The net amount recognized is included in the Consolidated Balance Sheets at December 31, 2024 and 2023 as follows:
| · · · · · · · · · · · · · | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| · · U.S. · · Non-U.S. | |||||||||
| · 2024 · 2023 · 2024 · 2023 | |||||||||
| Current nonpension postretirement benefit, included with Other accrued liabilities | | $(1) | | $(1) | | $(2) | | $(3) | |
| Nonpension postretirement benefits | | (18) | | (20) | | (44) | | (47) | |
| Accumulated other comprehensive loss | | (29) | | (29) | | (30) | | (35) | |
| Net amount recognized | | $(48) | | $(50) | | $(76) | | $(85) | |
The following changes in benefit obligations were recognized in Accumulated Other Comprehensive Loss at December 31, 2024 and 2023 as follows:
| · · · · · · · · · · · · · | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · U.S. · · Non-U.S. | ||||||||||||
| · 2024 · 2023 · 2024 · 2023 | ||||||||||||
| Current year actuarial (gain) loss | | $ | | | $— | | $(1) | | $3 | | ||
| Amortization of actuarial gain (loss) | | (9) | | (8) | | | 3 | | | 3 | | |
| Amortization of prior service credit | | 9 | | 9 | | | | | | | | |
| Foreign currency translation | | | | | | | | 3 | | | (1) | |
| | | $— | | $1 | | $5 | | $5 | | |||
The components of the net postretirement benefit cost for the year are as follows:
| | | | | | | | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · U.S. · · Non-U.S. | |||||||||||||||||||
| · 2024 · 2023 · 2022 · 2024 · 2023 · 2022 | |||||||||||||||||||
| Service cost | | $— | | $— | | $— | | $1 | | $1 | | $2 | | ||||||
| Interest cost | | 1 | | 1 | | 1 | | 2 | | 2 | | 2 | | ||||||
| Amortization: | | | | | | | | | | | | | | | | | | | |
| Actuarial (gain) loss | | 8 | | 8 | | 8 | | | (3) | | | (3) | | | | | |||
| Prior service credit | | (8) | | (9) | | (8) | | | | | | | | | | | |||
| Net amortization | | — | | (1) | | — | | (3) | | (3) | | — | | ||||||
| Net postretirement benefit cost | | $1 | | $— | | $1 | | $— | | $— | | $4 | | ||||||
Amortization included in net postretirement benefit cost is based on the average remaining service of employees. The weighted average discount rates used to determine the accumulated postretirement benefit obligation and net postretirement benefit cost are as follows:
| · · · · · · · · · · · · · | ||||||
|---|---|---|---|---|---|---|
| · · U.S. · · Non-U.S. | ||||||
| | 2024 | 2023 | 2022 | 2024 | 2023 | 2022 |
| Accumulated postretirement benefit obligation | 5.70% | 5.18% | 5.48% | 4.65% | 4.65% | 5.15% |
| Net postretirement benefit cost | 5.10% | 5.48% | 2.90% | 4.65% | 5.15% | 2.95% |
The weighted average assumed health care cost trend rates at December 31 are as follows:
| · · · · · · · · · | ||||||||
|---|---|---|---|---|---|---|---|---|
| · · U.S. · · Non-U.S. | ||||||||
| · 2024 · 2023 · 2024 · 2023 | ||||||||
| Health care cost trend rate assumed for next year | 6.5% | 6.3% | 5.0% | 5.0% | ||||
| Rate to which the cost trend rate is assumed to decline (ultimate trend rate) | 5.0% | 5.0% | 5.0% | 5.0% | ||||
| Year that the rate reaches the ultimate trend rate | 2032 | | 2032 | | N/A | | N/A | |
Amortization included in net postretirement benefit cost is based on the average remaining service of employees.
The following estimated future benefit payments, which reflect expected future service, as appropriate, are expected to be paid in the years indicated:
| · · · · · · · | |||||
|---|---|---|---|---|---|
| Year(s) · U.S. · Non-U.S. | |||||
| 2025 | | $1 | | $3 | |
| 2026 | | 1 | | 3 | |
| 2027 | | 1 | | 3 | |
| 2028 | | 1 | | 3 | |
| 2029 | | 1 | | 3 | |
| 2030 - 2034 | | 7 | | 14 | |
Other U.S. hourly retirees receive health and life insurance benefits from a multi-employer trust established by collective bargaining. Payments to the trust as required by the bargaining agreements are based upon specified amounts per hour worked and were$4 million in 2024, $5 million in 2023 and $5 million in 2022. Postretirement health and life benefits for retirees of foreign subsidiaries are generally provided through the national health care programs of the countries in which the subsidiaries are located.
12. Leases
The Company determines if an arrangement is a lease at inception. A contract is or contains a lease if it conveys the right to control the use of an identified asset for a period of time in exchange for consideration. Right-of-use assets represent the right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term.
The Company uses an estimated incremental borrowing rate at the lease commencement date to determine the present value of lease payments when the implicit rate is not readily determinable in the lease. The Company’s incremental borrowing rate reflects a fully secured rate based on recent debt issuances, the credit rating of the Company, changes in currency and repayment timing of the lease, as well as publicly available data for instruments with similar characteristics when calculating incremental borrowing rates.
Certain lease agreements include terms with options toextend thelease, however, none of these have been recognized in the Company’s right-of-use assets or lease liabilities since those options were not reasonably certain to be exercised. Leases with a term of 12 months or less are not recorded on the balance sheet and lease expense for these leases is recognized on a straight-line basis over the lease term. The Company’s lease agreements include lease payments that are largely fixed and do not contain material residual value guarantees or variable lease payments and no lease transactions with related parties. For the years ended December 31, 2024 and 2023, the Company’s lease costs associated with leases with terms less than 12 months or variable lease costs were immaterial. Certain leases include options to purchase the leased property. The depreciable life of assets and leasehold improvements are limited by the lease term, unless there is a transfer of title or purchase option reasonably certain of exercise. The Company’s leases do not contain restrictions or covenants that restrict the Company from incurring other financial obligations.
The Company leases warehouses, office buildings, equipment and certain land and buildings under both operating and finance lease arrangements. Information related to these leases is as follows:
| | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|
| · · · Year ended December 31, | |||||||||
| · 2024 · · · 2023 · · 2022 | |||||||||
| Lease cost | | | | | | | | | |
| Finance lease cost: | | | | | | | | | |
| Amortization of right-of-use assets (included in Cost of goods sold and Selling and administrative expense) | | $21 | | $15 | | $13 | |||
| Interest on lease liabilities (included in Interest expense, net) | | | 12 | | | 10 | | | 3 |
| Operating lease cost (included in Cost of goods sold and Selling and administrative expense) | | | 64 | | | 63 | | | 57 |
| Total lease cost | | $97 | | $88 | | $73 | |||
| | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|
| · · · Year ended December 31, | |||||||||
| | | | 2024 | | | 2023 | | | 2022 |
| Other information | | | | | | | | | |
| Cash paid for amounts included in the measurement of lease liabilities: | | | | | | | | | |
| Operating cash flows from operating leases | | $62 | | $60 | | $52 | |||
| Operating cash flows from finance leases | | | 12 | | | 10 | | | 3 |
| Financing cash flows from finance leases | | | 21 | | | 15 | | | 13 |
| Right-of-use assets obtained in exchange for new operating lease liabilities | | | 41 | | | 46 | | | 171 |
| | | | | | | |
|---|---|---|---|---|---|---|
| · · | ||||||
| · · December 31, | ||||||
| | | | 2024 | | | 2023 |
| Supplemental balance sheet information · · · · · | ||||||
| Operating leases: | | | | | | |
| Operating lease right-of-use assets (included in Other assets) | | $201 | | $220 | ||
| | | | | | | |
| Current operating lease liabilities (included in Other current liabilities) | | | 41 | | | 44 |
| Noncurrent operating lease liabilities (included in Other long-term liabilities) | | | 169 | | | 184 |
| Total operating lease liabilities | | $210 | | $228 | ||
| | | | | | | |
| Finance leases: | | | | | | |
| Property, plant and equipment | | $261 | | $238 | ||
| Accumulated amortization | | | (60) | | | (64) |
| Property, plant and equipment, net | | | 201 | | | 174 |
| | | | | | | |
| Current finance lease liabilities (included in Long-term debt due within one year) | | | 32 | | | 23 |
| Noncurrent finance lease liabilities (included in Long-term debt) | | | 163 | | | 151 |
| Total finance lease liabilities | | $195 | | $174 | ||
| | | | | | | |
| Weighted-average remaining lease term (in years): | | | | | | |
| Operating leases | | | 6.5 | | | 6.6 |
| Finance leases | | | 6.2 | | | 6.8 |
| Weighted-average discount rate: | | | | | | |
| Operating leases | | | 6.72% | | | 6.56% |
| Finance leases | | | 5.75% | | | 5.88% |
| | | | | | | |
|---|---|---|---|---|---|---|
| Maturity of lease liabilities | | | Operating leases | | | Finance leases |
| 2025 | | $54 | | $43 | ||
| 2026 | | | 46 | | | 42 |
| 2027 | | | 41 | | | 41 |
| 2028 | | | 29 | | | 37 |
| 2029 | | | 25 | | | 32 |
| 2030 and thereafter | | | 64 | | | 37 |
| Total lease payments | | | 259 | | | 232 |
| Less: imputed interest | | | (49) | | | (37) |
| Total lease obligations | | $210 | | $195 | ||
| | | | | | | |
| Minimum payments related to leases not yet commenced as of December 31, 2024 | | $— | | $— |
- Income Taxes
The provision for income taxes was calculated based on the following components of earnings (loss) before income taxes:
| · · · · · · · · · · | |||||||
|---|---|---|---|---|---|---|---|
| · 2024 · 2023 · 2022 | |||||||
| U.S. | | $(284) | | $(455) | | $1 | |
| Non-U.S. | | 322 | | 522 | | 804 | |
| | | $38 | | $67 | | $805 | |
The provision for income taxes consists of the following:
| | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|
| · 2024 · 2023 · 2022 | ||||||||||
| Current: | | | | | | | | | | |
| U.S. | | $13 | | $13 | | $14 | | |||
| Non-U.S. | | 106 | | 114 | | 142 | | |||
| | | 119 | | 127 | | 156 | | |||
| Deferred: | | | | | | | | | | |
| U.S. | | | — | | (16) | | (1) | | ||
| Non-U.S. | | 7 | | 41 | | 23 | | |||
| | | 7 | | 25 | | 22 | | |||
| Total: | | | | | | | | | | |
| U.S. | | 13 | | (3) | | 13 | | |||
| Non-U.S. | | 113 | | 155 | | 165 | | |||
| | | $126 | | $152 | | $178 | | |||
A reconciliation of the provision for income taxes based on the statutory U.S. Federal tax rate of 21% to the provision for income taxes is as follows:
| | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|
| · 2024 · 2023 · 2022 | ||||||||||
| Tax provision on pretax earnings at statutory U.S. Federal tax rate | | $8 | | $14 | | $169 | | |||
| Increase (decrease) in provision for income taxes due to: | | | | | | | | | | |
| Non-U.S. tax rates | | | 12 | | | 5 | | | 34 | |
| Global intangible low taxed income and Foreign-derived intangible income, net of applicable GILTI credits | | | 6 | | | 12 | | | 48 | |
| Goodwill impairment | | | | | | 85 | | | | |
| Divestitures and sale leasebacks of land and building | | | | | | | | | (34) | |
| Tax law changes | | (1) | | | 3 | | | (1) | | |
| Tax impact of Brazil indirect tax ruling | | | | | | | | | (6) | |
| Change in valuation allowance | | | 34 | | | 85 | | | (36) | |
| Tax attribute expiration | | | 17 | | | 7 | | | 6 | |
| Withholding tax | | | 12 | | | 14 | | | 24 | |
| Non-deductible expenses and taxable gains | | | 36 | | | 13 | | | 11 | |
| Tax credits and incentives | | | (24) | | | (34) | | | (25) | |
| Changes in tax reserves and audit settlements | | | 4 | | | (14) | | | (4) | |
| Mexico inflationary adjustments | | | (1) | | | (5) | | | (2) | |
| Equity earnings | | | (17) | | | (23) | | | (20) | |
| Intercompany financing | | | 18 | | | (13) | | | 4 | |
| Other taxes based on income | | | 6 | | | 6 | | | 5 | |
| Other items | | 16 | | | (3) | | | 5 | | |
| Provision for income taxes | | $126 | | $152 | | $178 | | |||
Deferred income taxes reflect: (1) the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and their relevant tax basis; and (2) carryovers and credits for income tax purposes.
Significant components of the Company’s deferred tax assets and liabilities at December 31, 2024 and 2023 are as follows:
| | | | | | | | |
|---|---|---|---|---|---|---|---|
| · 2024 · 2023 | |||||||
| Deferred tax assets: | | | | | | | |
| Accrued postretirement benefits | | $23 | | $23 | | ||
| Foreign tax credit carryovers | | 144 | | | 148 | | |
| Operating, capital loss and interest carryovers | | 357 | | | 339 | | |
| Other credit carryovers | | 29 | | | 27 | | |
| Accrued liabilities | | 75 | | | 75 | | |
| Pension liabilities | | 10 | | | 28 | | |
| Operating lease liabilities | | | 50 | | | 55 | |
| Other | | 61 | | | 86 | | |
| Total deferred tax assets | | 749 | | 781 | | ||
| Deferred tax liabilities: | | | | | | | |
| Property, plant and equipment | | 113 | | | 119 | | |
| Intangibles and deferred software | | 39 | | | 50 | | |
| Operating lease right-of-use assets | | | 48 | | | 53 | |
| Total deferred tax liabilities | | 200 | | 222 | | ||
| Valuation allowance | | (544) | | | (538) | | |
| Net deferred taxes | | $5 | | $21 | | ||
Deferred taxes are included in the Consolidated Balance Sheets at December 31, 2024 and 2023 as follows:
| · · · · · · · | |||||
|---|---|---|---|---|---|
| · 2024 · 2023 | |||||
| Other assets | | $79 | | $107 | |
| Deferred taxes | | (74) | | (86) | |
| Net deferred taxes | | $5 | | $21 | |
The deferred tax expense associated with the increase in the valuation allowance of $6 million was primarily allocated $21 million income from continuing operations due to the primacy of continuing operations, changes in tax law and movements in non-U.S. currencies, and $15 million decrease to other comprehensive income.
Deferred tax assets and liabilities are determined separately for each tax jurisdiction on a separate or on a consolidated tax filing basis, as applicable, in which the Company conducts its operations or otherwise incurs taxable income or losses. A valuation allowance is recorded when it is more likely than not that some portion or all of the gross deferred tax assets will not be realized. The realization of deferred tax assets depends on the ability to generate sufficient taxable income of the appropriate character within the carryback or carryforward periods provided for in the tax law for each applicable tax jurisdiction. The Company considers the following possible sources of taxable income when assessing the realization of deferred tax assets:
taxable income in prior carryback years;
future reversals of existing taxable temporary differences;
future taxable income exclusive of reversing temporary differences and carryforwards; and
prudent and feasible tax planning strategies that the Company would be willing to undertake to prevent a deferred tax asset from otherwise expiring.
The assessment regarding whether a valuation allowance is required or whether a change in judgment regarding the valuation allowance has occurred also considers all available positive and negative evidence, including but not limited to:
nature, frequency, and severity of cumulative losses in recent years;
duration of statutory carryforward and carryback periods;
statutory limitations against utilization of tax attribute carryforwards against taxable income;
historical experience with tax attributes expiring unused; and
near- and medium-term financial outlook.
The weight given to the positive and negative evidence is commensurate with the extent to which the evidence may be objectively verified. Accordingly, it is generally difficult to conclude a valuation allowance is not required when there is significant objective and verifiable negative evidence, such as cumulative losses in recent years. The Company uses the actual results for the last two years and current year results as the primary measure of cumulative losses in recent years.
The evaluation of deferred tax assets requires judgment in assessing the likely future tax consequences of events recognized in the financial statements or tax returns and future profitability. The recognition of deferred tax assets represents the Company’s best estimate of those future events. Changes in the current estimates, due to unanticipated events or otherwise, could have a material effect on the Company’s results of operations and financial condition.
In certain tax jurisdictions, the Company’s analysis indicates that it has cumulative losses in recent years. This is considered significant negative evidence, which is objective and verifiable and, therefore, difficult to overcome. However, the cumulative loss position is not solely determinative and, accordingly, the Company considers all other available positive and negative evidence in its analysis. Based on its analysis, the Company has recorded a valuation allowance for the portion of deferred tax assets where based on the weight of available evidence it is unlikely to realize those deferred tax assets.
Based on the evidence available including a lack of sustainable earnings, the Company in its judgment previously recorded a valuation allowance against substantially all of its net deferred tax assets in the United States. If a change in judgment regarding this valuation allowance were to occur in the future, the Company would record a potentially material deferred tax benefit, which could result in a favorable impact on the effective tax rate in that period. The utilization of tax attributes to offset taxable income reduces the amount of deferred tax assets subject to a valuation allowance. In addition, based on available evidence and the weighting of factors discussed above, the Company has valuation allowances on certain deferred tax assets in certain international tax jurisdictions.
At December 31, 2024, before valuation allowance, the Company had unused foreign tax credits of $144 million, including $58 million expiring in 2025 through 2033 and $86 million that can be carried over indefinitely. Approximately $288 million of the deferred tax assets related to operating, capital loss and interest
carryovers can be carried over indefinitely. The remaining operating, capital loss and interest carryforwards of $70 million expire between 2025 and 2044. Other credit carryovers include approximately $27 million of research tax credits expiring from 2025 to 2043.
Since a majority of the pre-2018 non-U.S. earnings (net of losses) were substantially taxed under the U.S. Tax Cuts and Jobs Act, distributions of those net earnings no longer attract significant U.S. income taxes except for any associated currency gains. Therefore, the Company does not assert that these net earnings (to the extent of foreign distributable reserves) and any associated gross book-tax basis differences, if any, are indefinitely reinvested. For all remaining gross book-tax basis differences in its non-U.S. consolidated subsidiaries, the Company maintains its assertion that it intends these to be indefinitely reinvested. The Company also records deferred foreign taxes on gross book-tax basis differences to the extent of foreign distributable reserves for certain foreign subsidiaries. Determining the amount of unrecognized deferred tax liability related to any remaining undistributed foreign earnings is not practicable.
The Company records a liability for unrecognized tax benefits related to uncertain tax positions. The Company accrues interest and penalties associated with unrecognized tax benefits as a component of its income tax expense.
The following is a reconciliation of the Company’s total gross unrecognized tax benefits for the years ended December 31, 2024, 2023 and 2022:
| | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|
| · 2024 · 2023 · 2022 | ||||||||||
| Balance at January 1 | | $41 | | $53 | | $95 | | |||
| Additions and reductions for tax positions of prior years | | | | | (15) | | | (10) | | |
| Additions based on tax positions related to the current year | | 5 | | | | | | | | |
| Reductions due to the lapse of the applicable statute of limitations | | | | | | | | | | |
| Reductions due to settlements | | | (24) | | | (1) | | | (31) | |
| Foreign currency translation | | (1) | | | 4 | | | (1) | | |
| Balance at December 31 | | $21 | | $41 | | $53 | | |||
| Unrecognized tax benefits, which if recognized, would impact the Company’s effective income tax rate | | $10 | | $25 | | $37 | | |||
| Accrued interest and penalties at December 31 | | $2 | | $9 | | $8 | | |||
| Interest and penalties included in tax expense for the years ended December 31 | | $(8) | | $1 | | $(8) | | |||
Based upon the outcome of tax examinations, judicial proceedings, or expiration of statute of limitations, it is reasonably possible that the ultimate resolution of these unrecognized tax benefits may result in a payment that is materially different from the current estimate of the tax liabilities. The Company believes that it is reasonably possible that the estimated liability could decrease up to approximately $7 million within the next 12 months. This is primarily the result of anticipated audit settlements or statute expirations in several taxing jurisdictions.
The Company is currently under income tax examination in various tax jurisdictions in which it operates, including Brazil, Canada, Colombia, France, Germany, Hungary, Indonesia, Italy, Peru and the United States. The years under examination range from 2004 through 2023. The Company has received tax assessments in excess of established reserves. The Company is contesting these tax assessments, and will continue to do so, including pursuing all available remedies, such as appeals and litigation, if necessary.
The Company believes that adequate provisions for all income tax uncertainties have been made. However, if tax assessments are settled against the Company at amounts in excess of established reserves, it could have a material impact to the Company’s consolidated results of operations, financial position or cash flows. During 2024, the Company concluded income tax audits in several jurisdictions, including Brazil, Canada, France, Indonesia, Mexico and Peru.
14. Debt
The following table summarizes the long-term debt of the Company at December 31, 2024 and 2023:
| | | | | | | | |
|---|---|---|---|---|---|---|---|
| | | | | | | | |
| · 2024 · 2023 | |||||||
| Secured Credit Agreement: | | | | | | | |
| Revolving Credit Facility: | | | | | | | |
| Revolving Loans | | $— | | $— | | ||
| Term Loans: | | | | | | | |
| Term Loan A | | | 1,338 | | 1,391 | | |
| Senior Notes: | | | | | | | |
| 3.125%, due 2024 (€58 million at December 31, 2023 ) | | | | | | 63 | |
| 6.375%, due 2025 | | | | | | 299 | |
| 5.375%, due 2025 | | | 17 | | | 17 | |
| 2.875%, due 2025 (€176 million at December 31, 2024 and €500 million at December 31, 2023) | | | 183 | | | 551 | |
| 6.625%, due 2027 | | | 609 | | | 608 | |
| 6.250%, due 2028 (€600 million) | | | 619 | | | 656 | |
| 5.250%, due 2029 (€500 million) | | | 514 | | | | |
| 4.750%, due 2030 | | | 397 | | | 396 | |
| 7.250%, due 2031 | | | 683 | | | 682 | |
| 7.375%, due 2032 | | | 296 | | | | |
| Finance leases | | | 195 | | | 174 | |
| Other | | 8 | | 3 | | ||
| Total long-term debt | | 4,859 | | 4,840 | | ||
| Less amounts due within one year | | 306 | | 142 | | ||
| Long-term debt | | $4,553 | | $4,698 | | ||
The Company presents debt issuance costs in the Consolidated Balance Sheets as a deduction of the carrying amount of the related debt liability.
On March 25, 2022, certain of the Company’s subsidiaries entered into a Credit Agreement and Syndicated Facility Agreement (the “Original Agreement”), which refinanced in full the previous credit agreement. The Original Agreement provided for up to$2.8 billion of borrowings pursuant to term loans, revolving credit facilities and a delayed draw term loan facility. The delayed draw term loan facility allowed for a one-time borrowing of up to $600 million, the proceeds of which were used, in addition to other consideration paid by the Company and/or its subsidiaries, to fund an asbestos settlement trust (the “Paddock Trust”) established in connection with the confirmed plan of reorganization of Paddock proposed by Paddock, O-I Glass and certain other parties in Paddock’s Chapter 11 case(see Note 15 for more information). On July 18, 2022, the Company drew down the$600 million delayed draw term loan to fund, together with other consideration, the Paddock Trust.
On August 30, 2022, certain of the Company’s subsidiaries entered into an Amendment No. 1 to its Credit Agreement and Syndicated Facility Agreement (the “Credit Agreement Amendment”), which amends the Original Agreement (as amended by the Credit Agreement Amendment, the “Credit Agreement”). The Credit Agreement Amendment provides for up to$500 million of additional borrowings in the form of term loans. The proceeds of such term loans were used, together with cash, to retire the $600 million delayed draw term loan. The term loans mature, and the revolving credit facilities terminate, in March 2027. The term loans borrowed under the Credit Agreement Amendment are secured by certain collateral of the Company and certain of its subsidiaries. In addition, the Credit Agreement Amendment makes modifications to certain loan documents, in order to give the Company increased flexibility to incur secured debt in the future.
At December 31, 2024, the Credit Agreement includes a $300 million revolving credit facility, a $950 million multicurrency revolving credit facility and $1.45 billion in term loan A facilities ($1.34 billion outstanding balance at December 31, 2024, net of debt issuance costs). At December 31, 2024, the Company had unused credit of$1.24 billion available under the revolving credit facilities as part of the Credit Agreement. The weighted average interest rate on borrowings outstanding under the Credit Agreement at December 31, 2024 was 6.32%.
The Credit Agreement contains various covenants that restrict, among other things and subject to certain exceptions, the ability of the Company to incur certain indebtedness and liens, make certain investments, become liable under contingent obligations in certain defined instances only, make restricted payments, make certain asset sales within guidelines and limits, engage in certain affiliate transactions, participate in sale and leaseback financing arrangements, alter its fundamental business, and amend certain subordinated debt obligations.
The Credit Agreement also containsone financial maintenance covenant, a Secured Leverage Ratio (as defined in the Credit Agreement), that requires the Company not to exceed a ratio of 2.50 x calculated by dividing consolidated Net Indebtedness that is then secured by Liens on property or assets of the Company and certain of its subsidiaries by Consolidated EBITDA, as each term is defined and as described in the Credit Agreement. The Secured Leverage Ratio could restrict the ability of the Company to undertake additional financing or acquisitions to the extent that such financing or acquisitions would cause the Secured Leverage Ratio to exceed the specified maximum.
Failure to comply with these covenants and restrictions could result in an event of default under the Credit Agreement. In such an event, the Company could not request additional borrowings under the revolving facilities, and all amounts outstanding under the Credit Agreement, together with accrued interest, could then be declared immediately due and payable. Upon the occurrence and for the duration of a payment event of default, an additional default interest rate equal to 2.0% per annum will apply to all overdue obligations under the Credit Agreement. If an event of default occurs under the Credit Agreement and the lenders cause all of the outstanding debt obligations under the Credit Agreement to become due and payable, this would result in a default under the indentures governing the Company’s outstanding debt securities and could lead to an acceleration of obligations related to these debt securities. As of December 31, 2024, the Company was in compliance with all covenants and restrictions in the Credit Agreement. In addition, the Company believes that it will remain in compliance for the term of the Credit Agreement and that its ability to borrow additional funds under the Credit Agreement will not be adversely affected by the covenants and restrictions.
The Total Leverage Ratio (as defined in the Credit Agreement) determines pricing under the Credit Agreement. The interest rate on borrowings under the Credit Agreement is, at the Company’s option, the Base Rate, Term SOFR or, for non-U.S. dollar borrowings only, the Eurocurrency Rate (each as defined in the Credit Agreement), plus an applicable margin. The applicable margin is linked to the Total Leverage Ratio. The margins range from 1.00% to 2.25% for Term SOFR loans and Eurocurrency Rate loans and from 0.00% to
1.25%for Base Rate loans. In addition, a commitment fee is payable on the unused revolving credit facility commitments ranging from 0.20% to 0.35% per annum linked to the Total Leverage Ratio.
Obligations under the Credit Agreement are secured by substantially all of the assets, excluding real estate and certain other excluded assets, of certain of the Company’s domestic subsidiaries and certain foreign subsidiaries. Such obligations are also secured by a pledge of intercompany debt and equity investments in certain of the Company’s domestic subsidiaries and, in the case of foreign obligations, of stock of certain foreign subsidiaries. All obligations under the Credit Agreement are guaranteed by certain domestic subsidiaries of the Company, and certain foreign obligations under the Credit Agreement are guaranteed by certain foreign subsidiaries of the Company.
In May 2024, the Company issued€500 million aggregate principal amount of senior notes that bear interest of 5.250% and mature on June 1, 2029. Also, in May 2024, the Company issued$300 million aggregate principal amount of senior notes that bear interest of 7.375% and mature on June 1, 2032. The senior notes were issued via private placements and are guaranteed by certain of the Company’s subsidiaries. The net proceeds, after deducting debt issuance costs, were used to repurchase and redeem the senior notes described in the May 2024 tender offer and redemption below.
In May 2024, the Company repurchased€323.4 million aggregate principal amount of the outstanding 2.875% Senior Notes due 2025 pursuant to a tender offer and redeemed$300 million aggregate principal amount of the outstanding 6.375% Senior Notes due 2025. The repurchase and redemption were funded with the proceeds from the May 2024 senior notes issuances described above. The Company recorded approximately$2 million of additional interest charges related to the senior note repurchases conducted in the second quarter of 2024 for note repurchase premiums and the write-off of unamortized finance fees. At December 31, 2024, approximately€176 million aggregate principal amount of the 2.875% Senior Notes due 2025 remained outstanding.
In May 2023, the Company issued€600 million aggregate principal amount of senior notes that bear interest at a rate of 6.250% per annum and mature on May 15, 2028. Also, in May 2023, the Company issued$690 million aggregate principal amount of senior notes that bear interest at a rate of 7.250% per annum and mature on May 15, 2031. The senior notes were issued via a private placement and are guaranteed by certain of the Company’s subsidiaries. The net proceeds, after deducting debt issuance costs were used to redeem the aggregate principal amount described in the May 2023 tender offers below.
In May 2023, the Company repurchased$142 million aggregate principal amount of the outstanding 5.875% Senior Notes due 2023,€666.7 million aggregate principal amount of the outstanding 3.125% Senior Notes due 2024, and$282.8 million aggregate principal amount of the outstanding 5.375% Senior Notes due 2025. The repurchases were funded with the proceeds from the May 2023 senior notes issuances described above. The Company recorded approximately$39 million of additional interest charges related to the senior note repurchases conducted in the second quarter of 2023 for note repurchase premiums, the write-off of unamortized finance fees and the settlement of a related interest rate swap. In August 2023, the Company redeemed approximately$108 million aggregate principal amount of its 5.875% Senior Notes due 2023. At December 31, 2024, approximately $17 million aggregate principal amount of the 5.375% Senior Notes due 2025 remained outstanding.
The Company assesses its capital raising and refinancing needs on an ongoing basis and may enter into additional credit facilities and seek to issue equity and/or debt securities in the domestic and international capital markets if market conditions are favorable. Also, depending on market conditions, the Company may elect to repurchase portions of its debt securities in the open market.
Annual maturities for all of the Company’s long-term debt through 2029 and thereafter are as follows: 2025, $306 million; 2026, $105 million; 2027, $1,838 million; 2028, $652 million; 2029, $543 million; and 2030 and thereafter, $1,415 million.
The carrying amounts reported for certain long-term debt obligations subject to frequently redetermined interest rates approximate fair value. Fair values for the Company’s significant fixed rate debt obligations are based on published market quotations and are classified as Level 1 in the fair value hierarchy. Fair values at December 31, 2024, of the Company’s significant fixed rate debt obligations are as follows:
| | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|
| · · · · · · · | ||||||||||
| · Principal Amount · Indicated Market Price · Fair Value · | ||||||||||
| Senior Notes: | | | | | | | | | | |
| 5.375%, due 2025 | | $17 | | 100.02 | | $17 | | |||
| 2.875%, due 2025 (€176 million at December 31, 2024) | | | 184 | | 99.49 | | | 183 | | |
| 6.625%, due 2027 | | | 612 | | | 99.87 | | | 611 | |
| 6.250%, due 2028 (€600 million) | | | 624 | | | 103.94 | | | 649 | |
| 5.250%, due 2029 (€500 million) | | | 520 | | | 102.26 | | | 532 | |
| 4.750%, due 2030 | | | 400 | | | 89.30 | | | 357 | |
| 7.250%, due 2031 | | | 690 | | | 97.34 | | | 672 | |
| 7.375%, due 2032 | | | 300 | | | 95.75 | | | 287 | |
| | | | | | | | | | | |
15. Contingencies
Asbestos
From 1948 to 1958, one of the Company’s former business units commercially produced and sold approximately $40 million of a high-temperature, calcium-silicate based pipe and block insulation material containing asbestos. The Company sold its insulation business unit in April 1958. The Company historically received claims from individuals alleging bodily injury and death as a result of exposure to asbestos from this product.
On December 26 and 27, 2019, the Company implemented the Corporate Modernization, whereby O-I Glass became the new parent entity with O-I Group and Paddock as direct, wholly owned subsidiaries, with Paddock as the successor-by-merger to O-I. The Company’s legacy asbestos-related liabilities remained within Paddock, with the Company’s glass-making operations remaining under O-I Group. As part of the Corporate Modernization transactions, O-I Glass entered into a support agreement with Paddock that required O-I Glass to provide funding to Paddock for all permitted uses, subject to the terms of the support agreement. The key objectives of the Paddock support agreement were to ensure that Paddock retained the ability to fund the costs and expenses of managing the Chapter 11 process, and ultimately settle current and future asbestos-related liabilities through the establishment of a trust as described below and fund certain other liabilities.
On January 6, 2020 (the “Petition Date”), Paddock voluntarily filed for relief under Chapter 11 of the United States Bankruptcy Code (the “Bankruptcy Code”) in the U.S. Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”) to equitably and finally resolve all of its current and future asbestos-related liabilities. O-I Glass and O-I Group were not included in the Chapter 11 filing. During the pendency of the Chapter 11 proceeding, the activities of Paddock became subject to review and oversight by the Bankruptcy Court. As a result, the Company no longer had exclusive control over Paddock’s activities. Therefore, Paddock was
deconsolidated as of the Petition Date, and its assets and liabilities were derecognized from the Company’s Consolidated Financial Statements on a prospective basis. Simultaneously, the Company recognized a liability related to the Paddock support agreement as required under applicable accounting standards.
On April 26, 2021, the Company announced that (i) Paddock, (ii) the Official Committee of Asbestos Personal Injury Claimants (the “ACC”), appointed in the Paddock Chapter 11 case as the representative of current Paddock asbestos claimants, and (iii) the Legal Representative of Future Asbestos Claimants (the “FCR”), appointed in the Paddock Chapter 11 case as the representative of future Paddock asbestos claimants, had reached an agreement in principle, supported by O-I Glass, by accepting a proposal from Paddock’s court-appointed mediators setting forth total consideration to fund a trust created under section 524(g) of the Bankruptcy Code upon the effective date of a plan of reorganization for Paddock (the “Effective Date”).
In connection with the agreement in principle, the Company recorded a charge of $154 million related to its potential liability under the Paddock support agreement as a recognizable subsequent event in the Company’s Consolidated Results of Operations for the quarter ended March 31, 2021, primarily related to an increase to Paddock’s asbestos reserve estimate in consideration for the channeling injunction to be included in the Plan (as defined below) protecting the Company and each of the Company Protected Parties (as defined below) from current and future asbestos-related personal injury claims, as well as certain other adjustments to Paddock’s assets and liabilities, including estimated professional fees and expenses to be incurred in confirming and implementing the Plan. This charge was recorded to Other income (expense), net in the Consolidated Results of Operations.
On January 12, 2022, Paddock, O-I Glass, the FCR and the ACC jointly filed the Plan of Reorganization for Paddock Enterprises, LLC Under Chapter 11 of the Bankruptcy Code, dated January 12, 2022 (including any supplements and exhibits thereto, as amended, modified or supplemented from time to time in accordance with the terms thereof, the “Plan”). Amended versions of the Plan were subsequently filed on February 14, 2022, April 1, 2022, and May 24, 2022. The Plan incorporates and implements the agreement in principle described herein. On May 26, 2022, the Bankruptcy Court entered an order confirming the Plan and recommending that the District Court affirm such confirmation. On June 22, 2022, the District Court entered an order affirming the confirmation order previously issued by the Bankruptcy Court. On July 8, 2022, the Effective Date of the Plan occurred.
Under the confirmed and effective Plan, the Paddock Trust was created pursuant to the provisions of section 524(g) of the Bankruptcy Code and was funded with $610 million in total consideration (“Settlement Consideration”). In exchange for the Settlement Consideration, the Company, each of its current and former affiliates and certain other related parties (the “Company Protected Parties”) received the benefit of a release from Paddock, and Paddock and the Company Protected Parties received the benefit of an injunction under section 524(g) of the Bankruptcy Code channeling current and future asbestos-related personal injury claims to the Paddock Trust and permanently enjoining the assertion of asbestos-related personal injury claims against Paddock and the Company Protected Parties. In addition, the Paddock Trust, Paddock and O-I Glass (on behalf of itself and the Company Protected Parties) entered into an agreement through which the Paddock Trust agreed to indemnify the Company Protected Parties against any attempts to evade the channeling injunction or to otherwise bring asbestos-related personal injury claims against any Company Protected Party after the Effective Date. As a result, the Plan provides for a full and final resolution of current and future asbestos-related personal injury claims, a full and final resolution of (and a release in favor of the Company and its affiliates for) all claims arising out of the Corporate Modernization and provides that upon the Effective Date (which occurred on July 8, 2022), all obligations owed under the support agreement would terminate. Consistent with the Plan, the support agreement was deemed rejected as of the Effective Date, and all obligations between the parties to the support agreement were terminated.
Pursuant to the Plan, Paddock issued a promissory note (the “Trust Note”) in the principal amount of $8.5 million to the Paddock Trust on the Effective Date, and the Company issued a pledge of the equity interests in reorganized Paddock to the Paddock Trust to secure the Trust Note. On July 18, 2022, the Company funded the Paddock Trust with $601.5 million, comprising $600 million borrowed under the Credit Agreement and $1.5 million from cash. On July 20, 2022, Paddock redeemed the Trust Note by paying $8.5 million in cash to the Paddock Trust, and the pledge of equity interests in reorganized Paddock was cancelled.
As a result of the funding of the Paddock Trust and the cancellation of the pledge of equity interests in reorganized Paddock, on July 20, 2022, the Company regained exclusive control over reorganized Paddock’s activities. Therefore, at that date in the third quarter of 2022, reorganized Paddock was reconsolidated, and its remaining assets totaling $18 million (including $12 million of cash and cash equivalents) and liabilities totaling $30 million were recognized in the Company’s Consolidated Financial Statements. The funding of the Paddock Trust and certain related expenses resulted in an operating cash outflow of $621 million in the Company’s Consolidated Cash Flows during 2022.
Other Matters
The Company has been identified by the U.S. Environmental Protection Agency (“EPA”) or a comparable state or federal agency as a potentially responsible party (“PRP”) at a number of sites in the U.S., including certain Comprehensive Environmental Response, Compensation, and Liability Act of 1980 (“CERCLA”) (Superfund) sites, as well as sites previously owned or operated by the Company. As an identified PRP, the Company may have liability for investigation, remediation and monitoring of contamination, as well as associated penalties and natural resource damages, if any. The Company has not had monetary sanctions imposed nor has the Company been notified of any potential monetary sanctions at any of the sites.
The Company has recorded aggregate accruals of approximately $35 million and $26 million (undiscounted)as of December 31, 2024 and December 31, 2023, respectively, for estimated future remediation and monitoring costs at these sites. Although the Company believes its accruals are adequate to cover its portion of future remediation and monitoring costs, there can be no assurance that the ultimate payments will not exceed the amount of the Company’s accruals and will not have a material effect on its results of operations, financial position and cash flows. Other than related to the site discussed below, any possible loss or range of potential loss that may be incurred in excess of the recorded accruals cannot be estimated.
As part of the above, from December 31, 1956 through June 1967, the Company, via a wholly owned subsidiary, owned and operated a paper mill located on the shore of the Cuyahoga River in Ohio, which is now part of the Cuyahoga Valley National Park that is managed by the National Park Service (“NPS”). The Company and the United States are currently engaged in litigation regarding the site in the U.S. District Court for the Northern District of Ohio (Akron), with the United States claiming that the Company should pay$50 million as a remedy for certain soils at the site as well as its past and anticipated future costs. The Company undertook sampling at the site in 2024 and has proposed settling this matter and has recorded charges of approximately$11 million in 2024 as its best estimate of this liability based on current information. These charges were recorded to Other expense, net in the Consolidated Results of Operations. While the Company believes it has meritorious defenses against this suit, if the proposed settlement is not accepted by the NPS and the lawsuit proceeds, the ultimate resolution of this matter could result in a loss in excess of the amount currently accrued. The trial related to this lawsuit is scheduled to take place in the second quarter of 2025.
In November 2023, the Autorita Garante della Concorrenza e del Mercato (the “Italian Competition Authority”) commenced an investigation into alleged anti-competitive conduct bynine glass manufacturers and distributors in Italy, including the Company’s subsidiary based in Italy, O-I Italy SpA (“O-I Italy”), and an Italian
joint venture in which O-I Italy owns a 50% interest, related to the sale of wine bottles in Italy. The Italian Competition Authority’s investigation is ongoing. To date, the Italian Competition Authority has not officially charged O-I Italy or its joint venture with any violations of competition law. If the Italian Competition Authority finds that the Company or any of its subsidiaries or joint ventures violated competition law, the Italian Competition Authority could levy fines, which could be material. At this stage, the Company is unable to predict the ultimate outcome of the investigation and any potential loss cannot be estimated.
Other litigation is pending against the Company, in some cases involving ordinary and routine claims incidental to the business of the Company and in others presenting allegations that are non-routine and involve compensatory, punitive or treble damage claims as well as other types of relief. The Company records a liability for such matters when it is both probable that the liability has been incurred and the amount of the liability can be reasonably estimated. Recorded amounts are reviewed and adjusted to reflect changes in the factors upon which the estimates are based, including additional information, negotiations, settlements and other events.
16. Accumulated Other Comprehensive Income (Loss)
The components of comprehensive income (loss) are: (a) net earnings; (b) change in fair value of certain derivative instruments; (c) pension and other postretirement benefit adjustments; and (d) foreign currency translation adjustments. The net effect of exchange rate fluctuations generally reflects changes in the relative strength of the U.S. dollar against major foreign currencies between the beginning and end of the year.
The following table lists the beginning balance, annual activity and ending balance of each component of accumulated other comprehensive income (loss):
| | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · · · · · · · · Total Accumulated | ||||||||||||
| · · Net Effect of · · Change in Certain · · · · Other | ||||||||||||
| · · Exchange Rate · · Derivative · · Employee · · Comprehensive | ||||||||||||
| · Fluctuations · Instruments · Benefit Plans · Loss | ||||||||||||
| Balance on January 1, 2022 | | $(1,290) | | $(21) | | $(661) | | $(1,972) | ||||
| Change before reclassifications | | | 10 | | | 60 | | | (24) | | | 46 |
| Amounts reclassified from accumulated other comprehensive income (loss) | | | | | | (27)(a) | | 69(b) | | 42 | ||
| Translation effect | | | | | | (5) | | | 21 | | | 16 |
| Tax effect | | | | | | (3) | | | 10 | | | 7 |
| Other comprehensive income (loss) attributable to the Company | | | 10 | | | 25 | | | 76 | | | 111 |
| Balance on December 31, 2022 | | | (1,280) | | | 4 | | | (585) | | | (1,861) |
| Change before reclassifications | | 331 | | | (68) | | | (26) | | 237 | ||
| Amounts reclassified from accumulated other comprehensive income | | | | | | 20(a) | | 33(b) | 53 | |||
| Translation effect | | | | | | (4) | | | (14) | | | (18) |
| Tax effect | | | | | | 5 | | | 4 | | 9 | |
| Other comprehensive income (loss) attributable to the Company | | 331 | | (47) | | (3) | | 281 | ||||
| Balance on December 31, 2023 | | | (949) | | | (43) | | | (588) | | | (1,580) |
| Change before reclassifications | | (486) | | | 28 | | | 40 | | (418) | ||
| Amounts reclassified from accumulated other comprehensive income (loss) | | | | | | (4)(a) | | 26(b) | 22 | |||
| Translation effect | | | | | | 2 | | | 4 | | | 6 |
| Tax effect | | | | | | 3 | | | (8) | | (5) | |
| Other comprehensive income (loss) attributable to the Company | | (486) | | 29 | | 62 | | (395) | ||||
| Balance on December 31, 2024 | | $(1,435) | | $(14) | | $(526) | | $(1,975) | ||||
| (a) | Amount is recorded to other income (expense), net and interest expense, net in the Consolidated Results of Operations (see Note 9 for additional information). |
|---|
| (b) | Amount is included in the computation of net periodic pension cost and net postretirement benefit cost (see Note 11 for additional information). |
|---|
17. Stock Based Compensation
The Company has various nonqualified plans approved by share owners under which it has granted restricted shares and performance vested restricted share units. At December 31, 2024, there were 8,724,261 shares available for grants under these plans. Total compensation cost for all grants of shares and units under these plans was$14 million, $43 million and $33 million for the years ended December 31, 2024, 2023, and 2022, respectively.
Restricted Shares and Restricted Share Units
Restricted share units granted to employees vest over three years beginning on the first anniversary. Granted but unvested restricted share units are forfeited upon termination, unless certain retirement criteria are met. Holders of vested restricted share units receiveone share of the Company’s common stock for each unit as units vest. Restricted share units granted to directors vest afterone year.
The fair value of the restricted shares and restricted share units is equal to the market price of the Company’s common stock on the date of the grant. The fair value of restricted shares and restricted share units, is amortized over the vesting periods which range fromone tothree years.
The activity of restricted shares and restricted share units is as follows:
| | | | | | | |
|---|---|---|---|---|---|---|
| · · Weighted | ||||||
| · · Number of · · Average | ||||||
| · · Restricted · · Grant-Date | ||||||
| · · Shares · · Fair Value | ||||||
| · · (thousands) · · (per share) | ||||||
| Nonvested at January 1, 2024 | 1,533 | | $15.15 | | ||
| Granted | 710 | | | 16.42 | | |
| Vested | (943) | | | 13.81 | | |
| Forfeited | (83) | | | 16.70 | | |
| Nonvested at December 31, 2024 | 1,217 | | 16.83 | | ||
| Awards granted during 2023 | | | | $15.15 | | |
| Awards granted during 2022 | | | | $11.94 | | |
| · · · · · · · · · · | |||||||
|---|---|---|---|---|---|---|---|
| · 2024 · 2023 · 2022 | |||||||
| Total fair value of shares vested | | $13 | | $11 | | $10 | |
Performance Vested Restricted Share Units
Performance vested restricted share units vest on January 1 of the third year following the year in which they are granted. Holders of vested units may receive up totwo shares of the Company’s common stock for each unit, depending upon the attainment of consolidated performance goals established by the Compensation and Talent Development Committee of the Company’s Board of Directors. If minimum goals are not met, no shares will be issued. Granted but unvested restricted share units are forfeited upon termination of employment, unless certain retirement criteria are met.
The fair value of each performance vested restricted share unit is equal to the product of the fair value of the Company’s common stock on the date of grant and the estimated number of shares into which the performance vested restricted share unit will be converted. The fair value of performance vested restricted share units is amortized ratably over the vesting period. Should the estimated number of shares into which the performance vested restricted share unit will be converted change, an adjustment will be recorded to recognize the accumulated difference in amortization between the revised and previous estimates.
Performance vested restricted share unit activity is as follows:
| · · · · · · | |||||
|---|---|---|---|---|---|
| · Number of Performance · Weighted Average | |||||
| · · Vested Restricted Shares · · Grant-Date Fair Value | |||||
| · · Units (thousands) · · (per unit) | |||||
| Nonvested at January 1, 2024 | 2,890 | | $16.18 | | |
| Granted | 1,726 | | 14.90 | | |
| Vested | (1,846) | | 12.07 | | |
| Forfeited/Cancelled | (77) | | 19.23 | | |
| Nonvested at December 31, 2024 | 2,693 | | 17.85 | | |
| Awards granted during 2023 | | | | $16.18 | |
| Awards granted during 2022 | | | | $12.19 | |
Approximately 1,846,000 shares were issued in 2024 with a fair value at issuance date of $22 million related to performance vested restricted share units.
As of December 31, 2024, there was $17 million of total unrecognized compensation cost related to all restricted shares, restricted share units and performance vested restricted share units. That cost is expected to be recognized over a weighted average period of approximatelytwo years.
18. Other Income (Expense), net
Other income (expense), net for the years ended December 31, 2024, 2023 and 2022 included the following:
| | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|
| · 2024 · 2023 · 2022 · | ||||||||||
| Goodwill impairment (see Note 7) | | $ | | | $(445) | | $ | | | |
| Restructuring, asset impairment and other charges | | | (206) | | | (100) | | | (53) | |
| Pension settlement and curtailment charges (see Note 11) | | | (5) | | | (19) | | | (20) | |
| Legacy environmental charge (see Note 15) | | | (11) | | | | | | | |
| Gain on sale of divested businesses and miscellaneous assets (see Note 21) | | | 6 | | | 4 | | | 55 | |
| Gain on sale leasebacks (see Note 21) | | | | | | | | | 334 | |
| Intangible amortization expense | | | (29) | | | (32) | | | (33) | |
| Royalty income | | | 21 | | | 24 | | | 24 | |
| Foreign currency exchange loss | | | 1 | | | (4) | | | (2) | |
| Other income (expense), net | | | (3) | | | (10) | | | (6) | |
| | | $(226) | | $(582) | | $299 | | |||
19. Earnings Per Share
The following table sets forth the computation of basic and diluted earnings per share:
| | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|
| · 2024 · 2023 · 2022 | ||||||||||
| Numerator: | | | | | | | | | | |
| Net earnings (loss) attributable to the Company | | $(106) | | $(103) | | $584 | | |||
| Denominator (in thousands): | | | | | | | | | | |
| Denominator for basic earnings per share-weighted average shares outstanding | | 154,552 | | 154,651 | | 155,309 | | |||
| Effect of dilutive securities: | | | | | | | | | | |
| Stock options and other | | | | | | 3,676 | | |||
| Denominator for diluted earnings per share-adjusted weighted average shares outstanding | | 154,552 | | 154,651 | | 158,985 | | |||
| Basic earnings per share: | | | | | | | | | | |
| Net earnings (loss) | | $(0.69) | | $(0.67) | | $3.76 | | |||
| Diluted earnings per share: | | | | | | | | | | |
| Net earnings (loss) | | $(0.69) | | $(0.67) | | $3.67 | | |||
The diluted earnings per share computation for the years ended December 31, 2024, 2023, and 2022 excludes 895,697,423,477 and 768,032 weighted average shares of common stock, respectively, due to their antidilutive effect, which includes options, unvested restricted stock units and performance vested restricted share units. Options were excluded because the exercise prices of the options were greater than the average market price of the shares of common stock. For the years ended December 31, 2024 and 2023, diluted earnings per share of common stock was equal to basic earnings per share of common stock due to the net loss attributable to the Company.
On December 26 and 27, 2019, the Company implemented the Corporate Modernization, which involved a series of transactions, including the Merger. Upon the effectiveness of the Merger, each share of O-I common stock held immediately prior to the Merger automatically converted into a right to receive an equivalent corresponding share of O-I Glass common stock, having the same designations, rights, powers and preferences and the qualifications, limitations, and restrictions as the corresponding share of O-I stock being converted.
In connection with the Merger and pursuant to the Merger Agreement, each option to purchase a share of O-I common stock, each award of restricted shares of O-I common stock, each award of time-based restricted stock units covering shares of O-I common stock, each award of performance-based restricted stock units covering shares of O-I common stock and each dividend equivalent covering one share of O-I common stock, in each case, that was outstanding immediately prior to the effective time of the Merger (collectively, the “Company Equity Awards”) was converted into an O-I Glass Equity Award. Each O-I Glass Equity Award continues to be subject to the same terms and conditions (including vesting schedule and performance, forfeiture and termination conditions) that applied to the corresponding Company Equity Award immediately prior to the effective time of the Merger.
20. Supplemental Cash Flow Information
Changes in the components of working capital related to operations (net of the effects related to acquisitions and divestitures) were as follows:
| | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|
| | 2024 | 2023 | 2022 | ||||||
| Decrease (increase) in current assets: | | | | | | | | | |
| Receivables - change in factoring | | $(7) | | $7 | | $54 | |||
| Receivables - all other changes | | | 21 | | | 144 | | | (137) |
| Inventories | | 35 | | (174) | | (61) | |||
| Prepaid expenses and other | | 10 | | 4 | | (6) | |||
| Increase (decrease) in current liabilities: | | | | | | | | | |
| Accounts payable | | (95) | | (102) | | 146 | |||
| Accrued liabilities | | (6) | | (4) | | 45 | |||
| Salaries and wages | | (38) | | (20) | | 19 | |||
| U.S. and foreign income taxes | | | (45) | | (3) | | 35 | ||
| | | $(125) | | $(148) | | $95 | |||
The Company uses various factoring programs to sell certain trade receivables to financial institutions as part of managing its cash flows. Sales of trade receivables are accounted for in accordance with ASC Topic 860, Transfers and Servicing. Trade receivables sold under the factoring programs are transferred without recourse to the Company and accounted for as true sales and, therefore, are excluded from Trade receivables, net in the Consolidated Balance Sheets. At December 31, 2024, 2023 and 2022, the total amount of trade receivables sold by the Company was$535 million, $542 million and $535 million, respectively. These amounts included$155 million, $178 million and $158 million at December 31, 2024, 2023 and 2022, respectively, for trade receivable amounts factored under supply-chain financing programs linked to commercial arrangements with key customers. For the years ended December 31, 2024, 2023 and 2022, the Company recorded expenses related to these factoring programs of $24 million, $23 million and $11 million, respectively. The Company is the master servicer for the factoring programs that are not associated with key customers and is responsible for administering and collecting receivables.
In accordance with ASU 2022-04, “Liabilities-Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations,” the Company has agreements with third-party administrators that allow participating vendors to track the Company’s payments and, if voluntarily elected by the vendor, to sell payment obligations from the Company to financial institutions as part of a Supply Chain Financing (“SCF”) Program. The Company's payment terms to the financial institutions, including the timing and amount of payments, are based on the original supplier invoices. When participating vendors elect to sell one or more of the Company’s payment obligations, the Company’s rights and obligations to settle the payables on their contractual due date are not impacted. The Company has no economic or commercial interest in a vendor’s decision to enter into these agreements, and the financial institutions do not provide the Company with incentives, such as rebates or profit sharing under the SCF Program. The Company agrees on commercial terms with vendors for the goods and services procured, which are consistent with payment terms observed at other peer companies in the industry, and the terms are not impacted by the SCF Program. Such obligations are classified as accounts payable in its Consolidated Balance Sheets. The Company does not provide asset pledges, or other forms of guarantees, as security for the committed payment to the financial institutions. As of December 31, 2024 and December 31, 2023, the Company had approximately $82 million and $113 million, respectively, of outstanding payment obligations to the financial institutions as part of the SCF Program.
The Company’s outstanding obligations under the SCF Program are as follows:
| | | | | |
|---|---|---|---|---|
| · · Twelve Months Ended December, 31 | ||||
| | 2024 | |||
| Confirmed obligations outstanding at the beginning of the year | | $113 | | |
| Invoices confirmed during the year | | 394 | | |
| Confirmed invoices paid during the year | | | (425) | |
| Confirmed obligations outstanding at the end of the year | | $82 | | |
Income taxes paid in cash were as follows:
| · · · · · · · · · · | |||||||
|---|---|---|---|---|---|---|---|
| · 2024 · 2023 · 2022 · | |||||||
| U.S. | | $13 | | $16 | | $14 | |
| Non-U.S. | | 148 | | 131 | | 157 | |
| Total income taxes paid in cash | | $161 | | $147 | | $171 | |
Interest paid in cash, including note repurchase premiums, for the years ended December 31, 2024, 2023 and 2022 was $344 million, $301 million and $234 million, respectively. Cash interest for the years ended December 31, 2024, 2023 and 2022 included$0, $3 million and $17 million of note repurchase premiums, respectively.
21. Divestitures****and Sale Leasebacks of Land and Buildings
For the year ended December 31, 2024, the Company recorded a pretax gain of approximately $6 million on the sale of the land and buildings of previously closed plants in the Americas.
For the year ended December 31, 2023, the Company recorded a pretax gain of approximately $4 million on the sale of the land and buildings of a previously closed plant in China.
For the year ended December 31, 2022, the Company recorded pretax gains of approximately $334 million on the sale of land and buildings oftwo of its plants in the Americas and a pretax gain of $55 million related to the sale of the Company’s glass tableware business in Colombia. Additional details of these transactions are described below.
In August 2022, the Company completed the sale of the land and building related to its Vernon, California (Los Angeles) plant to 2900 Fruitland Avenue Investors LLC and 2901 Fruitland Avenue Investors LLC (“Fruitland”). Proceeds from the sale were approximately $181 million and the Company recorded a pretax gain of approximately $153 million (approximately $153 million after tax) on the sale, which is reflected in Other income (expense), net in the Consolidated Results of Operations.
In connection with this transaction, the Company entered into a lease for the land and building with Fruitland for the Vernon, California plant for an initial term of 10 years. The lease requires the Company to make rent payments of approximately$7.2 million in the first year, gradually increasing to approximately$10.3 million in the tenth year. The lease is classified as operating and was recorded as a right-of-useasset.
In May 2022, the Company completed the sale of the land and building related to its Brampton, Ontario, Canada plant to an affiliate of Crestpoint Real Estate Investments Ltd. (“Crestpoint”). Net proceeds were approximately $190 million, and the Company recorded a pretax gain of approximately $181 million (approximately $158 million after tax) on the sale, which is reflected in Other income (expense), net in the Consolidated Results of Operations.
In connection with this transaction, the Company entered into a lease for the land and building with Crestpoint for the Brampton, Ontario plant for an initial term of 10 years. The lease requires the Company to make rent payments of approximately$7.3 million in the first year, gradually increasing to approximately$9.1 million in the tenth year. The lease is classified as operating and was recorded as a right-of-useasset.
In March 2022, the Company completed the sale of its Cristar TableTop S.A.S. business to Vidros Colombia S.A.S, an affiliate of Nadir Figueiredo S.A., a glass tableware producer based in Brazil. Gross proceeds received were approximately $96 millionand the related pretax gain recorded was approximately$55 million (approximately$16 million after tax and noncontrolling interest) in the first quarter of 2022. The pretax gain was recorded to Other income (expense), net in the Consolidated Results of Operations.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.